#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-14	Classification	_
1-2	15-17	of	_
1-3	18-35	cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-4	36-48	participants	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-5	49-53	with	_
1-6	54-61	dynamic	_
1-7	62-72	functional	_
1-8	73-85	connectivity	_
1-9	86-90	from	_
1-10	91-101	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-11	102-110	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-12	111-120	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-13	121-128	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-14	129-133	data	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-15	134-140	Static	_
1-16	141-151	functional	_
1-17	152-164	connectivity	_
1-18	165-166	(	_
1-19	167-169	FC	_
1-20	170-171	)	_
1-21	172-180	analyses	_
1-22	181-186	based	_
1-23	187-189	on	_
1-24	190-200	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-25	201-209	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-26	210-219	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-27	220-227	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-28	228-229	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-29	230-234	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-30	235-236	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-31	237-241	data	_
1-32	242-246	have	_
1-33	247-251	been	_
1-34	252-263	extensively	_
1-35	264-272	explored	_
1-36	273-276	for	_
1-37	277-285	studying	_
1-38	286-293	various	_
1-39	294-305	psychiatric	_
1-40	306-316	conditions	_
1-41	317-319	in	_
1-42	320-323	the	_
1-43	324-329	brain	_
1-44	330-331	,	_
1-45	332-341	including	_
1-46	342-349	cocaine	_
1-47	350-359	addiction	_
1-48	360-361	.	_

2-1	362-363	A	_
2-2	364-372	recently	_
2-3	373-381	emerging	_
2-4	382-383	,	_
2-5	384-388	more	_
2-6	389-397	powerful	_
2-7	398-407	technique	_
2-8	408-409	,	_
2-9	410-417	dynamic	_
2-10	418-428	functional	_
2-11	429-441	connectivity	_
2-12	442-443	(	_
2-13	444-447	DFC	_
2-14	448-449	)	_
2-15	450-451	,	_
2-16	452-459	studies	_
2-17	460-463	how	_
2-18	464-467	the	_
2-19	468-470	FC	_
2-20	471-479	dynamics	_
2-21	480-486	change	_
2-22	487-493	during	_
2-23	494-497	the	_
2-24	498-504	course	_
2-25	505-507	of	_
2-26	508-511	the	_
2-27	512-516	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-28	517-528	experiments	_
2-29	529-530	.	_

3-1	531-534	The	_
3-2	535-538	aim	_
3-3	539-541	in	_
3-4	542-546	this	_
3-5	547-552	paper	_
3-6	553-556	was	_
3-7	557-559	to	_
3-8	560-567	develop	_
3-9	568-569	a	_
3-10	570-583	computational	_
3-11	584-592	approach	_
3-12	593-594	,	_
3-13	595-600	using	_
3-14	601-602	a	_
3-15	603-610	machine	_
3-16	611-619	learning	_
3-17	620-629	framework	_
3-18	630-631	,	_
3-19	632-634	to	_
3-20	635-644	determine	_
3-21	645-647	if	_
3-22	648-651	DFC	_
3-23	652-660	features	_
3-24	661-665	were	_
3-25	666-670	more	_
3-26	671-681	successful	_
3-27	682-686	than	_
3-28	687-689	FC	_
3-29	690-698	features	_
3-30	699-701	in	_
3-31	702-705	the	_
3-32	706-720	classification	_
3-33	721-723	of	_
3-34	724-741	cocaine-dependent	_
3-35	742-750	patients	_
3-36	751-754	and	_
3-37	755-762	healthy	_
3-38	763-771	controls	_
3-39	772-773	.	_

4-1	774-778	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-2	779-783	data	_
4-3	784-788	were	_
4-4	789-797	obtained	_
4-5	798-802	from	_
4-6	803-805	of	_
4-7	806-808	25	_
4-8	809-816	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-9	817-820	and	_
4-10	821-823	58	_
4-11	824-841	cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
4-12	842-854	participants	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
4-13	855-860	while	_
4-14	861-871	performing	_
4-15	872-873	a	_
4-16	874-879	motor	http://maven.renci.org/NeuroBridge/neurobridge#MotorSkillDisorder
4-17	880-888	response	_
4-18	889-899	inhibition	_
4-19	900-904	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
4-20	905-906	,	_
4-21	907-911	stop	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
4-22	912-918	signal	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
4-23	919-923	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
4-24	924-925	.	_

5-1	926-931	Group	_
5-2	932-943	independent	_
5-3	944-953	component	_
5-4	954-962	analysis	_
5-5	963-966	was	_
5-6	967-974	carried	_
5-7	975-978	out	_
5-8	979-981	on	_
5-9	982-985	all	_
5-10	986-997	participant	_
5-11	998-1002	data	_
5-12	1003-1005	to	_
5-13	1006-1013	compute	_
5-14	1014-1023	spatially	_
5-15	1024-1035	independent	_
5-16	1036-1046	components	_
5-17	1047-1048	(	_
5-18	1049-1052	ICs	_
5-19	1053-1054	)	_
5-20	1055-1056	.	_

6-1	1057-1062	Eight	_
6-2	1063-1066	ICs	_
6-3	1067-1071	were	_
6-4	1072-1080	selected	_
6-5	1081-1089	manually	_
6-6	1090-1092	as	_
6-7	1093-1101	relevant	_
6-8	1102-1107	brain	_
6-9	1108-1116	networks	_
6-10	1117-1118	,	_
6-11	1119-1124	which	_
6-12	1125-1129	were	_
6-13	1130-1134	used	_
6-14	1135-1137	to	_
6-15	1138-1146	classify	_
6-16	1147-1154	healthy	_
6-17	1155-1161	versus	_
6-18	1162-1179	cocaine-dependent	_
6-19	1180-1192	participants	_
6-20	1193-1194	.	_

7-1	1195-1197	FC	_
7-2	1198-1201	and	_
7-3	1202-1205	DFC	_
7-4	1206-1214	measures	_
7-5	1215-1217	of	_
7-6	1218-1221	the	_
7-7	1222-1228	chosen	_
7-8	1229-1231	IC	_
7-9	1232-1237	pairs	_
7-10	1238-1242	were	_
7-11	1243-1247	used	_
7-12	1248-1250	as	_
7-13	1251-1259	features	_
7-14	1260-1263	for	_
7-15	1264-1267	the	_
7-16	1268-1282	classification	_
7-17	1283-1292	algorithm	_
7-18	1293-1294	.	_

8-1	1295-1302	Support	_
8-2	1303-1309	Vector	_
8-3	1310-1318	Machines	_
8-4	1319-1323	were	_
8-5	1324-1328	used	_
8-6	1329-1332	for	_
8-7	1333-1337	both	_
8-8	1338-1345	feature	_
8-9	1346-1365	selection/reduction	_
8-10	1366-1369	and	_
8-11	1370-1381	participant	_
8-12	1382-1396	classification	_
8-13	1397-1398	.	_

9-1	1399-1404	Based	_
9-2	1405-1407	on	_
9-3	1408-1411	DFC	_
9-4	1412-1416	with	_
9-5	1417-1421	only	_
9-6	1422-1427	seven	_
9-7	1428-1430	IC	_
9-8	1431-1436	pairs	_
9-9	1437-1438	,	_
9-10	1439-1451	participants	_
9-11	1452-1456	were	_
9-12	1457-1469	successfully	_
9-13	1470-1480	classified	_
9-14	1481-1485	with	_
9-15	1486-1488	95	_
9-16	1489-1490	%	_
9-17	1491-1499	accuracy	_
9-18	1500-1501	(	_
9-19	1502-1505	and	_
9-20	1506-1510	with	_
9-21	1511-1513	90	_
9-22	1514-1515	%	_
9-23	1516-1524	accuracy	_
9-24	1525-1529	with	_
9-25	1530-1535	three	_
9-26	1536-1538	IC	_
9-27	1539-1544	pairs	_
9-28	1545-1546	)	_
9-29	1547-1548	,	_
9-30	1549-1556	whereas	_
9-31	1557-1563	static	_
9-32	1564-1566	FC	_
9-33	1567-1574	yielded	_
9-34	1575-1579	only	_
9-35	1580-1582	81	_
9-36	1583-1584	%	_
9-37	1585-1593	accuracy	_
9-38	1594-1595	.	_

10-1	1596-1602	Visual	_
10-2	1603-1604	,	_
10-3	1605-1617	sensorimotor	_
10-4	1618-1619	,	_
10-5	1620-1627	default	_
10-6	1628-1632	mode	_
10-7	1633-1634	,	_
10-8	1635-1638	and	_
10-9	1639-1648	executive	_
10-10	1649-1656	control	_
10-11	1657-1665	networks	_
10-12	1666-1667	,	_
10-13	1668-1676	amygdala	_
10-14	1677-1678	,	_
10-15	1679-1682	and	_
10-16	1683-1689	insula	_
10-17	1690-1696	played	_
10-18	1697-1700	the	_
10-19	1701-1705	most	_
10-20	1706-1717	significant	_
10-21	1718-1722	role	_
10-22	1723-1725	in	_
10-23	1726-1729	the	_
10-24	1730-1739	DFC-based	_
10-25	1740-1754	classification	_
10-26	1755-1756	.	_

11-1	1757-1762	These	_
11-2	1763-1771	findings	_
11-3	1772-1779	support	_
11-4	1780-1783	the	_
11-5	1784-1787	use	_
11-6	1788-1790	of	_
11-7	1791-1800	DFC-based	_
11-8	1801-1815	classification	_
11-9	1816-1818	of	_
11-10	1819-1823	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-11	1824-1828	data	_
11-12	1829-1831	as	_
11-13	1832-1833	a	_
11-14	1834-1843	potential	_
11-15	1844-1853	biomarker	_
11-16	1854-1857	for	_
11-17	1858-1861	the	_
11-18	1862-1876	identification	_
11-19	1877-1879	of	_
11-20	1880-1887	cocaine	_
11-21	1888-1898	dependence	_
11-22	1899-1900	.	_

12-1	1901-1908	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-2	1909-1912	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-3	1913-1922	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-4	1923-1935	Participants	_
12-5	1936-1944	Research	_
12-6	1945-1957	participants	_
12-7	1958-1962	were	_
12-8	1963-1965	58	_
12-9	1966-1983	cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
12-10	1984-1995	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
12-11	1996-1999	and	_
12-12	2000-2002	25	_
12-13	2003-2014	age-matched	_
12-14	2015-2022	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-15	2023-2031	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-16	2032-2033	.	_

13-1	2034-2051	Cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
13-2	2052-2064	participants	_
13-3	2065-2069	were	_
13-4	2070-2079	recruited	_
13-5	2080-2084	from	_
13-6	2085-2090	three	_
13-7	2091-2102	residential	_
13-8	2103-2112	treatment	_
13-9	2113-2121	programs	_
13-10	2122-2124	in	_
13-11	2125-2131	Dallas	_
13-12	2132-2133	,	_
13-13	2134-2139	Texas	_
13-14	2140-2141	:	_
13-15	2142-2145	the	_
13-16	2146-2148	VA	_
13-17	2149-2154	North	_
13-18	2155-2160	Texas	_
13-19	2161-2167	Health	_
13-20	2168-2172	Care	_
13-21	2173-2179	System	_
13-22	2180-2181	,	_
13-23	2182-2190	Homeward	_
13-24	2191-2196	Bound	_
13-25	2197-2198	,	_
13-26	2199-2203	Inc.	_
13-27	2204-2205	,	_
13-28	2206-2209	and	_
13-29	2210-2215	Nexus	_
13-30	2216-2224	Recovery	_
13-31	2225-2231	Center	_
13-32	2232-2233	,	_
13-33	2234-2237	Inc	_
13-34	2238-2239	.	_

14-1	2240-2252	Participants	_
14-2	2253-2257	were	_
14-3	2258-2269	financially	_
14-4	2270-2281	compensated	_
14-5	2282-2285	for	_
14-6	2286-2291	their	_
14-7	2292-2305	participation	_
14-8	2306-2307	.	_

15-1	2308-2311	The	_
15-2	2312-2320	criteria	_
15-3	2321-2324	for	_
15-4	2325-2332	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
15-5	2333-2343	dependence	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
15-6	2344-2347	was	_
15-7	2348-2351	the	_
15-8	2352-2362	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-9	2363-2371	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-10	2372-2381	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-11	2382-2385	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-12	2386-2395	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-13	2396-2400	Axis	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-14	2401-2402	I	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-15	2403-2412	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
15-16	2413-2414	;	_
15-17	2415-2418	all	_
15-18	2419-2436	cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
15-19	2437-2449	participants	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
15-20	2450-2458	endorsed	_
15-21	2459-2466	cocaine	_
15-22	2467-2469	as	_
15-23	2470-2475	their	_
15-24	2476-2483	primary	_
15-25	2484-2488	drug	_
15-26	2489-2491	of	_
15-27	2492-2498	choice	_
15-28	2499-2500	.	_

16-1	2501-2518	Cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
16-2	2519-2531	participants	_
16-3	2532-2536	were	_
16-4	2537-2549	administered	_
16-5	2550-2551	a	_
16-6	2552-2565	comprehensive	_
16-7	2566-2573	medical	_
16-8	2574-2581	history	_
16-9	2582-2585	and	_
16-10	2586-2594	physical	_
16-11	2595-2606	examination	_
16-12	2607-2608	,	_
16-13	2609-2610	a	_
16-14	2611-2618	general	_
16-15	2619-2629	laboratory	_
16-16	2630-2635	panel	_
16-17	2636-2637	,	_
16-18	2638-2643	urine	_
16-19	2644-2648	drug	_
16-20	2649-2655	screen	_
16-21	2656-2657	,	_
16-22	2658-2661	and	_
16-23	2662-2663	a	_
16-24	2664-2670	guided	_
16-25	2671-2680	interview	_
16-26	2681-2683	of	_
16-27	2684-2692	lifetime	_
16-28	2693-2702	substance	_
16-29	2703-2706	use	_
16-30	2707-2714	history	_
16-31	2715-2721	during	_
16-32	2722-2725	the	_
16-33	2726-2731	first	_
16-34	2732-2735	and	_
16-35	2736-2742	second	_
16-36	2743-2747	week	_
16-37	2748-2750	of	_
16-38	2751-2760	inpatient	_
16-39	2761-2770	treatment	_
16-40	2771-2772	.	_

17-1	2773-2785	Participants	_
17-2	2786-2790	were	_
17-3	2791-2799	excluded	_
17-4	2800-2802	if	_
17-5	2803-2807	they	_
17-6	2808-2811	had	_
17-7	2812-2815	any	_
17-8	2816-2823	history	_
17-9	2824-2826	of	_
17-10	2827-2832	major	_
17-11	2833-2840	illness	_
17-12	2841-2842	,	_
17-13	2843-2846	had	_
17-14	2847-2849	an	_
17-15	2850-2859	estimated	_
17-16	2860-2862	IQ	_
17-17	2863-2868	below	_
17-18	2869-2871	70	_
17-19	2872-2873	(	_
17-20	2874-2877	per	_
17-21	2878-2881	the	_
17-22	2882-2890	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
17-23	2891-2895	Test	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
17-24	2896-2898	of	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
17-25	2899-2904	Adult	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
17-26	2905-2912	Reading	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
17-27	2913-2914	)	_
17-28	2915-2916	,	_
17-29	2917-2920	met	_
17-30	2921-2929	criteria	_
17-31	2930-2933	for	_
17-32	2934-2937	any	_
17-33	2938-2950	neurological	_
17-34	2951-2953	or	_
17-35	2954-2960	active	_
17-36	2961-2965	Axis	_
17-37	2966-2967	I	_
17-38	2968-2976	disorder	_
17-39	2977-2978	(	_
17-40	2979-2984	other	_
17-41	2985-2989	than	_
17-42	2990-2999	substance	_
17-43	3000-3003	use	_
17-44	3004-3013	disorders	_
17-45	3014-3015	)	_
17-46	3016-3017	,	_
17-47	3018-3020	or	_
17-48	3021-3025	were	_
17-49	3026-3028	on	_
17-50	3029-3032	any	_
17-51	3033-3040	central	_
17-52	3041-3048	nervous	_
17-53	3049-3055	system	_
17-54	3056-3062	active	_
17-55	3063-3074	medications	_
17-56	3075-3076	(	_
17-57	3077-3086	including	_
17-58	3087-3090	all	_
17-59	3091-3104	psychotropics	_
17-60	3105-3106	)	_
17-61	3107-3108	.	_

18-1	3109-3114	Other	_
18-2	3115-3119	drug	_
18-3	3120-3123	use	_
18-4	3124-3129	among	_
18-5	3130-3147	cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
18-6	3148-3159	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
18-7	3160-3163	was	_
18-8	3164-3167	not	_
18-9	3168-3169	a	_
18-10	3170-3179	criterion	_
18-11	3180-3183	for	_
18-12	3184-3193	exclusion	_
18-13	3194-3195	,	_
18-14	3196-3198	as	_
18-15	3199-3203	long	_
18-16	3204-3206	as	_
18-17	3207-3214	cocaine	_
18-18	3215-3225	dependence	_
18-19	3226-3229	was	_
18-20	3230-3233	the	_
18-21	3234-3241	primary	_
18-22	3242-3251	diagnosis	_
18-23	3252-3253	.	_

19-1	3254-3256	15	_
19-2	3257-3259	of	_
19-3	3260-3263	the	_
19-4	3264-3266	CD	_
19-5	3267-3279	participants	_
19-6	3280-3284	also	_
19-7	3285-3288	had	_
19-8	3289-3296	history	_
19-9	3297-3299	of	_
19-10	3300-3307	alcohol	_
19-11	3308-3309	,	_
19-12	3310-3317	whereas	_
19-13	3318-3322	none	_
19-14	3323-3325	of	_
19-15	3326-3329	the	_
19-16	3330-3332	CD	_
19-17	3333-3345	participants	_
19-18	3346-3349	had	_
19-19	3350-3357	alcohol	_
19-20	3358-3363	abuse	_
19-21	3364-3371	history	_
19-22	3372-3373	.	_

20-1	3374-3391	Cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
20-2	3392-3404	participants	_
20-3	3405-3409	were	_
20-4	3410-3419	recruited	_
20-5	3420-3429	following	_
20-6	3430-3439	admission	_
20-7	3440-3442	to	_
20-8	3443-3446	one	_
20-9	3447-3449	of	_
20-10	3450-3455	three	_
20-11	3456-3467	residential	_
20-12	3468-3475	cocaine	_
20-13	3476-3486	dependence	_
20-14	3487-3496	treatment	_
20-15	3497-3505	programs	_
20-16	3506-3508	in	_
20-17	3509-3515	Dallas	_
20-18	3516-3517	,	_
20-19	3518-3523	Texas	_
20-20	3524-3525	,	_
20-21	3526-3529	and	_
20-22	3530-3534	were	_
20-23	3535-3543	admitted	_
20-24	3544-3546	as	_
20-25	3547-3551	soon	_
20-26	3552-3554	as	_
20-27	3555-3563	possible	_
20-28	3564-3569	after	_
20-29	3570-3575	their	_
20-30	3576-3580	last	_
20-31	3581-3589	reported	_
20-32	3590-3593	use	_
20-33	3594-3596	of	_
20-34	3597-3604	cocaine	_
20-35	3605-3606	.	_

21-1	3607-3610	All	_
21-2	3611-3616	three	_
21-3	3617-3625	programs	_
21-4	3626-3634	utilized	_
21-5	3635-3638	the	_
21-6	3639-3648	Minnesota	_
21-7	3649-3654	Model	_
21-8	3655-3667	psychosocial	_
21-9	3668-3677	treatment	_
21-10	3678-3686	approach	_
21-11	3687-3688	.	_

22-1	3689-3694	Urine	_
22-2	3695-3699	drug	_
22-3	3700-3707	screens	_
22-4	3708-3712	were	_
22-5	3713-3722	conducted	_
22-6	3723-3733	throughout	_
22-7	3734-3745	residential	_
22-8	3746-3755	treatment	_
22-9	3756-3758	to	_
22-10	3759-3765	verify	_
22-11	3766-3776	abstinence	_
22-12	3777-3778	.	_

23-1	3779-3782	The	_
23-2	3783-3787	time	_
23-3	3788-3790	in	_
23-4	3791-3800	treatment	_
23-5	3801-3807	varied	_
23-6	3808-3815	between	_
23-7	3816-3817	2	_
23-8	3818-3821	and	_
23-9	3822-3823	4	_
23-10	3824-3829	weeks	_
23-11	3830-3831	.	_

24-1	3832-3836	This	_
24-2	3837-3841	time	_
24-3	3842-3847	frame	_
24-4	3848-3855	allowed	_
24-5	3856-3859	the	_
24-6	3860-3870	resolution	_
24-7	3871-3873	of	_
24-8	3874-3881	cocaine	_
24-9	3882-3894	intoxication	_
24-10	3895-3896	,	_
24-11	3897-3904	cocaine	_
24-12	3905-3915	withdrawal	_
24-13	3916-3924	symptoms	_
24-14	3925-3926	,	_
24-15	3927-3930	and	_
24-16	3931-3941	reasonable	_
24-17	3942-3951	stability	_
24-18	3952-3954	of	_
24-19	3955-3960	other	_
24-20	3961-3965	mood	_
24-21	3966-3974	symptoms	_
24-22	3975-3980	while	_
24-23	3981-3990	remaining	_
24-24	3991-3993	in	_
24-25	3994-3995	a	_
24-26	3996-4005	monitored	_
24-27	4006-4017	residential	_
24-28	4018-4025	setting	_
24-29	4026-4027	.	_

25-1	4028-4030	It	_
25-2	4031-4034	was	_
25-3	4035-4046	anticipated	_
25-4	4047-4051	that	_
25-5	4052-4063	variability	_
25-6	4064-4068	with	_
25-7	4069-4073	this	_
25-8	4074-4079	small	_
25-9	4080-4086	window	_
25-10	4087-4089	of	_
25-11	4090-4100	abstinence	_
25-12	4101-4103	in	_
25-13	4104-4105	a	_
25-14	4106-4120	substance-free	_
25-15	4121-4122	,	_
25-16	4123-4134	residential	_
25-17	4135-4144	treatment	_
25-18	4145-4152	program	_
25-19	4153-4158	would	_
25-20	4159-4161	be	_
25-21	4162-4169	minimal	_
25-22	4170-4171	.	_

26-1	4172-4175	All	_
26-2	4176-4188	participants	_
26-3	4189-4197	admitted	_
26-4	4198-4202	into	_
26-5	4203-4206	the	_
26-6	4207-4212	three	_
26-7	4213-4222	treatment	_
26-8	4223-4231	programs	_
26-9	4232-4236	over	_
26-10	4237-4238	a	_
26-11	4239-4245	4-year	_
26-12	4246-4252	period	_
26-13	4253-4257	were	_
26-14	4258-4266	screened	_
26-15	4267-4268	.	_

27-1	4269-4277	Informed	_
27-2	4278-4285	consent	_
27-3	4286-4289	was	_
27-4	4290-4298	obtained	_
27-5	4299-4301	on	_
27-6	4302-4305	180	_
27-7	4306-4318	participants	_
27-8	4319-4320	(	_
27-9	4321-4323	46	_
27-10	4324-4330	female	_
27-11	4331-4332	,	_
27-12	4333-4336	134	_
27-13	4337-4341	male	_
27-14	4342-4343	)	_
27-15	4344-4345	.	_

28-1	4346-4352	Ninety	_
28-2	4353-4358	seven	_
28-3	4359-4363	were	_
28-4	4364-4372	excluded	_
28-5	4373-4377	from	_
28-6	4378-4381	the	_
28-7	4382-4390	analyses	_
28-8	4391-4393	of	_
28-9	4394-4398	this	_
28-10	4399-4404	paper	_
28-11	4405-4408	due	_
28-12	4409-4411	to	_
28-13	4412-4415	not	_
28-14	4416-4423	meeting	_
28-15	4424-4433	inclusion	_
28-16	4434-4442	criteria	_
28-17	4443-4444	,	_
28-18	4445-4450	early	_
28-19	4451-4460	discharge	_
28-20	4461-4465	from	_
28-21	4466-4473	program	_
28-22	4474-4475	,	_
28-23	4476-4478	or	_
28-24	4479-4489	withdrawal	_
28-25	4490-4492	of	_
28-26	4493-4500	consent	_
28-27	4501-4503	or	_
28-28	4504-4513	technical	_
28-29	4514-4522	problems	_
28-30	4523-4527	with	_
28-31	4528-4532	fMRI	_
28-32	4533-4537	data	_
28-33	4538-4539	.	_

29-1	4540-4547	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
29-2	4548-4555	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
29-3	4556-4568	participants	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
29-4	4569-4572	had	_
29-5	4573-4575	no	_
29-6	4576-4584	lifetime	_
29-7	4585-4592	history	_
29-8	4593-4595	of	_
29-9	4596-4605	substance	_
29-10	4606-4609	use	_
29-11	4610-4618	disorder	_
29-12	4619-4620	.	_

30-1	4621-4626	Other	_
30-2	4627-4638	psychiatric	_
30-3	4639-4640	,	_
30-4	4641-4648	medical	_
30-5	4649-4650	,	_
30-6	4651-4654	and	_
30-7	4655-4664	cognitive	_
30-8	4665-4674	exclusion	_
30-9	4675-4683	criteria	_
30-10	4684-4688	were	_
30-11	4689-4696	similar	_
30-12	4697-4699	to	_
30-13	4700-4704	that	_
30-14	4705-4707	of	_
30-15	4708-4711	the	_
30-16	4712-4729	cocaine-dependent	_
30-17	4730-4742	participants	_
30-18	4743-4744	.	_

31-1	4745-4748	All	_
31-2	4749-4756	aspects	_
31-3	4757-4759	of	_
31-4	4760-4763	the	_
31-5	4764-4772	research	_
31-6	4773-4781	protocol	_
31-7	4782-4786	were	_
31-8	4787-4795	reviewed	_
31-9	4796-4799	and	_
31-10	4800-4808	approved	_
31-11	4809-4811	by	_
31-12	4812-4815	the	_
31-13	4816-4829	Institutional	_
31-14	4830-4836	Review	_
31-15	4837-4843	Boards	_
31-16	4844-4846	of	_
31-17	4847-4850	the	_
31-18	4851-4861	University	_
31-19	4862-4864	of	_
31-20	4865-4870	Texas	_
31-21	4871-4883	Southwestern	_
31-22	4884-4891	Medical	_
31-23	4892-4898	Center	_
31-24	4899-4901	at	_
31-25	4902-4908	Dallas	_
31-26	4909-4912	and	_
31-27	4913-4916	the	_
31-28	4917-4925	Veterans	_
31-29	4926-4940	Administration	_
31-30	4941-4946	North	_
31-31	4947-4952	Texas	_
31-32	4953-4959	Health	_
31-33	4960-4964	Care	_
31-34	4965-4971	System	_
31-35	4972-4973	.	_

32-1	4974-4986	Participants	_
32-2	4987-4993	signed	_
32-3	4994-4996	an	_
32-4	4997-5005	informed	_
32-5	5006-5013	consent	_
32-6	5014-5020	before	_
32-7	5021-5026	study	_
32-8	5027-5040	participation	_
32-9	5041-5044	and	_
32-10	5045-5049	were	_
32-11	5050-5061	compensated	_
32-12	5062-5065	for	_
32-13	5066-5071	their	_
32-14	5072-5085	participation	_
32-15	5086-5087	.	_

33-1	5088-5096	Relevant	_
33-2	5097-5108	demographic	_
33-3	5109-5112	and	_
33-4	5113-5121	clinical	_
33-5	5122-5137	characteristics	_
33-6	5138-5140	of	_
33-7	5141-5144	the	_
33-8	5145-5157	participants	_
33-9	5158-5161	are	_
33-10	5162-5170	provided	_
33-11	5171-5173	in	_
33-12	5174-5179	Table	_
33-13	5180-5181	1	_
33-14	5182-5183	.	_

34-1	5184-5187	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
34-2	5188-5192	data	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
34-3	5193-5204	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
34-4	5205-5222	Cocaine-dependent	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
34-5	5223-5234	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
34-6	5235-5244	completed	_
34-7	5245-5250	scans	_
34-8	5251-5257	during	_
34-9	5258-5263	their	_
34-10	5264-5269	final	_
34-11	5270-5274	week	_
34-12	5275-5277	of	_
34-13	5278-5279	a	_
34-14	5280-5282	2-	_
34-15	5283-5285	to	_
34-16	5286-5292	4-week	_
34-17	5293-5304	residential	_
34-18	5305-5314	treatment	_
34-19	5315-5322	program	_
34-20	5323-5324	.	_

35-1	5325-5337	Participants	_
35-2	5338-5347	completed	_
35-3	5348-5352	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
35-4	5353-5358	scans	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
35-5	5359-5365	during	_
35-6	5366-5371	which	_
35-7	5372-5376	they	_
35-8	5377-5381	were	_
35-9	5382-5392	instructed	_
35-10	5393-5395	to	_
35-11	5396-5399	lie	_
35-12	5400-5402	as	_
35-13	5403-5408	still	_
35-14	5409-5411	as	_
35-15	5412-5420	possible	_
35-16	5421-5425	with	_
35-17	5426-5431	their	_
35-18	5432-5436	eyes	_
35-19	5437-5441	open	_
35-20	5442-5443	.	_

36-1	5444-5447	Two	_
36-2	5448-5455	control	_
36-3	5456-5468	participants	_
36-4	5469-5473	were	_
36-5	5474-5482	excluded	_
36-6	5483-5487	from	_
36-7	5488-5491	all	_
36-8	5492-5499	imaging	_
36-9	5500-5508	analysis	_
36-10	5509-5512	due	_
36-11	5513-5515	to	_
36-12	5516-5517	a	_
36-13	5518-5527	technical	_
36-14	5528-5533	error	_
36-15	5534-5540	during	_
36-16	5541-5552	acquisition	_
36-17	5553-5555	of	_
36-18	5556-5559	the	_
36-19	5560-5567	resting	_
36-20	5568-5572	data	_
36-21	5573-5574	.	_

37-1	5575-5585	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-2	5586-5589	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-3	5590-5601	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-4	5602-5605	was	_
37-5	5606-5615	performed	_
37-6	5616-5618	on	_
37-7	5619-5620	a	_
37-8	5621-5628	Philips	_
37-9	5629-5631	3T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-10	5632-5640	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-11	5641-5650	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-12	5651-5658	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-13	5659-5660	(	_
37-14	5661-5668	Philips	_
37-15	5669-5676	Medical	_
37-16	5677-5684	Systems	_
37-17	5685-5686	,	_
37-18	5687-5691	Best	_
37-19	5692-5693	,	_
37-20	5694-5697	The	_
37-21	5698-5709	Netherlands	_
37-22	5710-5711	)	_
37-23	5712-5713	.	_

38-1	5714-5718	BOLD	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
38-2	5719-5723	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
38-3	5724-5728	data	_
38-4	5729-5735	during	_
38-5	5736-5739	the	_
38-6	5740-5743	SST	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
38-7	5744-5754	experiment	_
38-8	5755-5759	were	_
38-9	5760-5768	acquired	_
38-10	5769-5774	using	_
38-11	5775-5776	a	_
38-12	5777-5788	single-shot	_
38-13	5789-5800	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
38-14	5801-5808	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
38-15	5809-5817	sequence	_
38-16	5818-5822	with	_
38-17	5823-5827	3.25	_
38-18	5828-5829	χ	_
38-19	5830-5834	3.25	_
38-20	5835-5838	mm2	_
38-21	5839-5847	in-plane	_
38-22	5848-5858	resolution	_
38-23	5859-5860	,	_
38-24	5861-5863	36	_
38-25	5864-5870	slices	_
38-26	5871-5872	(	_
38-27	5873-5886	thickness/gap	_
38-28	5887-5888	=	_
38-29	5889-5892	3/0	_
38-30	5893-5895	mm	_
38-31	5896-5897	)	_
38-32	5898-5899	,	_
38-33	5900-5913	field-of-view	_
38-34	5914-5915	(	_
38-35	5916-5919	FOV	_
38-36	5920-5921	)	_
38-37	5922-5925	208	_
38-38	5926-5927	×	_
38-39	5928-5931	208	_
38-40	5932-5933	×	_
38-41	5934-5937	108	_
38-42	5938-5940	mm	_
38-43	5941-5942	,	_
38-44	5943-5949	matrix	_
38-45	5950-5954	size	_
38-46	5955-5957	64	_
38-47	5958-5959	×	_
38-48	5960-5962	64	_
38-49	5963-5964	×	_
38-50	5965-5967	36	_
38-51	5968-5969	,	_
38-52	5970-5980	repetition	_
38-53	5981-5990	time/echo	_
38-54	5991-5995	time	_
38-55	5996-5997	=	_
38-56	5998-6006	1,700/25	_
38-57	6007-6019	milliseconds	_
38-58	6020-6021	,	_
38-59	6022-6035	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
38-60	6036-6047	echo-planar	_
38-61	6048-6055	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-62	6056-6057	(	_
38-63	6058-6061	EPI	_
38-64	6062-6063	)	_
38-65	6064-6068	with	_
38-66	6069-6073	flip	_
38-67	6074-6079	angle	_
38-68	6080-6083	70°	_
38-69	6084-6085	,	_
38-70	6086-6089	and	_
38-71	6090-6093	384	_
38-72	6094-6101	volumes	_
38-73	6102-6106	over	_
38-74	6107-6110	the	_
38-75	6111-6119	duration	_
38-76	6120-6122	of	_
38-77	6123-6128	about	_
38-78	6129-6132	653	_
38-79	6133-6135	s.	_
38-80	6136-6139	For	_
38-81	6140-6147	spatial	_
38-82	6148-6161	normalization	_
38-83	6162-6170	purposes	_
38-84	6171-6172	,	_
38-85	6173-6188	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
38-86	6189-6200	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-87	6201-6207	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-88	6208-6212	were	_
38-89	6213-6221	acquired	_
38-90	6222-6226	with	_
38-91	6227-6228	a	_
38-92	6229-6236	spatial	_
38-93	6237-6247	resolution	_
38-94	6248-6250	of	_
38-95	6251-6252	1	_
38-96	6253-6254	×	_
38-97	6255-6256	1	_
38-98	6257-6258	×	_
38-99	6259-6260	1	_
38-100	6261-6264	mm3	_
38-101	6265-6266	.	_

39-1	6267-6271	Stop	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
39-2	6272-6278	signal	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
39-3	6279-6283	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
39-4	6284-6287	The	_
39-5	6288-6292	task	_
39-6	6293-6296	has	_
39-7	6297-6307	previously	_
39-8	6308-6312	been	_
39-9	6313-6321	proposed	_
39-10	6322-6325	and	_
39-11	6326-6335	described	_
39-12	6336-6338	by	_
39-13	6339-6342	and	_
39-14	6343-6347	been	_
39-15	6348-6352	used	_
39-16	6353-6355	to	_
39-17	6356-6364	classify	_
39-18	6365-6369	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
39-19	6370-6374	from	_
39-20	6375-6382	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
39-21	6383-6391	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
39-22	6392-6396	with	_
39-23	6397-6403	almost	_
39-24	6404-6406	80	_
39-25	6407-6408	%	_
39-26	6409-6423	classification	_
39-27	6424-6432	accuracy	_
39-28	6433-6434	.	_

40-1	6435-6442	Goggles	_
40-2	6443-6447	were	_
40-3	6448-6452	used	_
40-4	6453-6456	for	_
40-5	6457-6465	stimulus	_
40-6	6466-6478	presentation	_
40-7	6479-6480	.	_

41-1	6481-6482	A	_
41-2	6483-6488	rapid	_
41-3	6489-6500	mixed-trial	_
41-4	6501-6514	event-related	_
41-5	6515-6519	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
41-6	6520-6526	design	_
41-7	6527-6530	was	_
41-8	6531-6535	used	_
41-9	6536-6537	.	_

42-1	6538-6548	Horizontal	_
42-2	6549-6554	white	_
42-3	6555-6561	arrows	_
42-4	6562-6563	(	_
42-5	6564-6565	“	_
42-6	6566-6568	Go	_
42-7	6569-6570	”	_
42-8	6571-6579	stimulus	_
42-9	6580-6581	)	_
42-10	6582-6584	on	_
42-11	6585-6586	a	_
42-12	6587-6592	black	_
42-13	6593-6603	background	_
42-14	6604-6612	pointing	_
42-15	6613-6619	either	_
42-16	6620-6624	left	_
42-17	6625-6627	or	_
42-18	6628-6633	right	_
42-19	6634-6642	appeared	_
42-20	6643-6646	for	_
42-21	6647-6650	500	_
42-22	6651-6653	ms	_
42-23	6654-6658	with	_
42-24	6659-6660	a	_
42-25	6661-6665	mean	_
42-26	6666-6680	inter-stimulus	_
42-27	6681-6689	interval	_
42-28	6690-6691	(	_
42-29	6692-6695	ISI	_
42-30	6696-6697	)	_
42-31	6698-6700	of	_
42-32	6701-6704	1.8	_
42-33	6705-6706	s	_
42-34	6707-6708	(	_
42-35	6709-6712	1.6	_
42-36	6713-6714	,	_
42-37	6715-6718	1.8	_
42-38	6719-6720	,	_
42-39	6721-6724	2.0	_
42-40	6725-6726	s	_
42-41	6727-6728	)	_
42-42	6729-6730	.	_

43-1	6731-6734	The	_
43-2	6735-6740	three	_
43-3	6741-6745	ISIs	_
43-4	6746-6750	were	_
43-5	6751-6759	randomly	_
43-6	6760-6769	presented	_
43-7	6770-6772	to	_
43-8	6773-6781	optimize	_
43-9	6782-6793	statistical	_
43-10	6794-6804	efficiency	_
43-11	6805-6806	.	_

44-1	6807-6819	Participants	_
44-2	6820-6824	were	_
44-3	6825-6835	instructed	_
44-4	6836-6838	to	_
44-5	6839-6843	make	_
44-6	6844-6845	a	_
44-7	6846-6852	button	_
44-8	6853-6861	response	_
44-9	6862-6864	to	_
44-10	6865-6867	Go	_
44-11	6868-6875	signals	_
44-12	6876-6880	with	_
44-13	6881-6886	their	_
44-14	6887-6891	left	_
44-15	6892-6894	or	_
44-16	6895-6900	right	_
44-17	6901-6906	thumb	_
44-18	6907-6920	corresponding	_
44-19	6921-6923	to	_
44-20	6924-6927	the	_
44-21	6928-6933	arrow	_
44-22	6934-6943	direction	_
44-23	6944-6946	as	_
44-24	6947-6951	soon	_
44-25	6952-6954	as	_
44-26	6955-6963	possible	_
44-27	6964-6965	.	_

45-1	6966-6968	In	_
45-2	6969-6972	the	_
45-3	6973-6986	unpredictable	_
45-4	6987-6988	,	_
45-5	6989-6999	infrequent	_
45-6	7000-7004	Stop	_
45-7	7005-7011	trials	_
45-8	7012-7013	(	_
45-9	7014-7016	74	_
45-10	7017-7021	Stop	_
45-11	7022-7028	trials	_
45-12	7029-7030	,	_
45-13	7031-7044	approximately	_
45-14	7045-7047	20	_
45-15	7048-7049	%	_
45-16	7050-7052	of	_
45-17	7053-7056	the	_
45-18	7057-7063	trials	_
45-19	7064-7065	)	_
45-20	7066-7067	,	_
45-21	7068-7078	horizontal	_
45-22	7079-7085	arrows	_
45-23	7086-7090	were	_
45-24	7091-7099	followed	_
45-25	7100-7101	(	_
45-26	7102-7107	after	_
45-27	7108-7109	a	_
45-28	7110-7118	variable	_
45-29	7119-7126	250–900	_
45-30	7127-7129	ms	_
45-31	7130-7135	delay	_
45-32	7136-7137	)	_
45-33	7138-7139	,	_
45-34	7140-7142	by	_
45-35	7143-7151	vertical	_
45-36	7152-7158	arrows	_
45-37	7159-7167	pointing	_
45-38	7168-7174	upward	_
45-39	7175-7176	(	_
45-40	7177-7178	“	_
45-41	7179-7183	Stop	_
45-42	7184-7185	”	_
45-43	7186-7194	stimulus	_
45-44	7195-7196	)	_
45-45	7197-7198	.	_

46-1	7199-7211	Participants	_
46-2	7212-7216	were	_
46-3	7217-7227	instructed	_
46-4	7228-7230	to	_
46-5	7231-7238	inhibit	_
46-6	7239-7244	their	_
46-7	7245-7253	response	_
46-8	7254-7256	to	_
46-9	7257-7260	the	_
46-10	7261-7270	preceding	_
46-11	7271-7273	Go	_
46-12	7274-7282	stimulus	_
46-13	7283-7287	when	_
46-14	7288-7289	a	_
46-15	7290-7294	Stop	_
46-16	7295-7300	arrow	_
46-17	7301-7304	was	_
46-18	7305-7314	presented	_
46-19	7315-7320	after	_
46-20	7321-7324	the	_
46-21	7325-7327	Go	_
46-22	7328-7336	stimulus	_
46-23	7337-7338	.	_

47-1	7339-7342	The	_
47-2	7343-7348	delay	_
47-3	7349-7356	between	_
47-4	7357-7359	Go	_
47-5	7360-7363	and	_
47-6	7364-7368	Stop	_
47-7	7369-7376	stimuli	_
47-8	7377-7380	was	_
47-9	7381-7389	titrated	_
47-10	7390-7391	,	_
47-11	7392-7401	according	_
47-12	7402-7404	to	_
47-13	7405-7409	each	_
47-14	7410-7421	participant	_
47-15	7422-7423	’	_
47-16	7424-7425	s	_
47-17	7426-7437	performance	_
47-18	7438-7439	.	_

48-1	7440-7443	The	_
48-2	7444-7452	tracking	_
48-3	7453-7462	algorithm	_
48-4	7463-7466	was	_
48-5	7467-7475	designed	_
48-6	7476-7478	to	_
48-7	7479-7485	assure	_
48-8	7486-7489	the	_
48-9	7490-7494	task	_
48-10	7495-7498	was	_
48-11	7499-7506	equally	_
48-12	7507-7518	challenging	_
48-13	7519-7522	for	_
48-14	7523-7527	each	_
48-15	7528-7538	individual	_
48-16	7539-7540	,	_
48-17	7541-7550	providing	_
48-18	7551-7553	50	_
48-19	7554-7555	%	_
48-20	7556-7566	successful	_
48-21	7567-7568	(	_
48-22	7569-7580	StopSuccess	_
48-23	7581-7582	)	_
48-24	7583-7586	and	_
48-25	7587-7589	50	_
48-26	7590-7591	%	_
48-27	7592-7604	unsuccessful	_
48-28	7605-7606	(	_
48-29	7607-7615	StopFail	_
48-30	7616-7617	)	_
48-31	7618-7628	inhibition	_
48-32	7629-7635	trials	_
48-33	7636-7637	.	_

49-1	7638-7650	Seventy-four	_
49-2	7651-7655	Stop	_
49-3	7656-7662	trials	_
49-4	7663-7664	(	_
49-5	7665-7671	evenly	_
49-6	7672-7683	distributed	_
49-7	7684-7691	between	_
49-8	7692-7697	right	_
49-9	7698-7701	and	_
49-10	7702-7706	left	_
49-11	7707-7709	Go	_
49-12	7710-7716	arrows	_
49-13	7717-7718	)	_
49-14	7719-7723	were	_
49-15	7724-7739	pseudo-randomly	_
49-16	7740-7752	interspersed	_
49-17	7753-7757	with	_
49-18	7758-7761	288	_
49-19	7762-7764	Go	_
49-20	7765-7771	trials	_
49-21	7772-7773	.	_

50-1	7774-7784	Successive	_
50-2	7785-7789	Stop	_
50-3	7790-7796	trials	_
50-4	7797-7801	were	_
50-5	7802-7811	separated	_
50-6	7812-7814	by	_
50-7	7815-7817	at	_
50-8	7818-7823	least	_
50-9	7824-7829	three	_
50-10	7830-7832	Go	_
50-11	7833-7839	trials	_
50-12	7840-7842	to	_
50-13	7843-7848	allow	_
50-14	7849-7855	better	_
50-15	7856-7866	separation	_
50-16	7867-7869	of	_
50-17	7870-7873	the	_
50-18	7874-7885	hemodynamic	_
50-19	7886-7894	response	_
50-20	7895-7896	.	_

51-1	7897-7901	Stop	_
51-2	7902-7905	and	_
51-3	7906-7908	Go	_
51-4	7909-7915	trials	_
51-5	7916-7920	were	_
51-6	7921-7928	equally	_
51-7	7929-7940	distributed	_
51-8	7941-7948	between	_
51-9	7949-7954	right	_
51-10	7955-7958	and	_
51-11	7959-7963	left	_
51-12	7964-7970	arrows	_
51-13	7971-7972	.	_

52-1	7973-7976	The	_
52-2	7977-7983	number	_
52-3	7984-7986	of	_
52-4	7987-7991	Stop	_
52-5	7992-7995	and	_
52-6	7996-7998	Go	_
52-7	7999-8005	trials	_
52-8	8006-8007	,	_
52-9	8008-8010	74	_
52-10	8011-8014	and	_
52-11	8015-8018	288	_
52-12	8019-8020	,	_
52-13	8021-8033	respectively	_
52-14	8034-8035	,	_
52-15	8036-8040	were	_
52-16	8041-8044	the	_
52-17	8045-8049	same	_
52-18	8050-8053	for	_
52-19	8054-8058	each	_
52-20	8059-8070	participant	_
52-21	8071-8072	.	_

53-1	8073-8084	Performance	_
53-2	8085-8087	on	_
53-3	8088-8091	the	_
53-4	8092-8095	SST	_
53-5	8096-8099	was	_
53-6	8100-8110	calculated	_
53-7	8111-8114	for	_
53-8	8115-8119	each	_
53-9	8120-8131	participant	_
53-10	8132-8133	.	_

54-1	8134-8137	The	_
54-2	8138-8142	Stop	_
54-3	8143-8149	Signal	_
54-4	8150-8158	Response	_
54-5	8159-8163	Time	_
54-6	8164-8165	(	_
54-7	8166-8170	SSRT	_
54-8	8171-8172	)	_
54-9	8173-8175	is	_
54-10	8176-8179	the	_
54-11	8180-8184	time	_
54-12	8185-8193	required	_
54-13	8194-8197	for	_
54-14	8198-8199	a	_
54-15	8200-8211	participant	_
54-16	8212-8214	to	_
54-17	8215-8221	cancel	_
54-18	8222-8227	their	_
54-19	8228-8236	movement	_
54-20	8237-8242	after	_
54-21	8243-8249	seeing	_
54-22	8250-8253	the	_
54-23	8254-8258	stop	_
54-24	8259-8265	signal	_
54-25	8266-8267	,	_
54-26	8268-8273	where	_
54-27	8274-8280	longer	_
54-28	8281-8286	SSRTs	_
54-29	8287-8295	indicate	_
54-30	8296-8302	poorer	_
54-31	8303-8311	response	_
54-32	8312-8322	inhibition	_
54-33	8323-8324	.	_

55-1	8325-8329	SSRT	_
55-2	8330-8333	was	_
55-3	8334-8344	calculated	_
55-4	8345-8347	by	_
55-5	8348-8359	subtracting	_
55-6	8360-8363	the	_
55-7	8364-8371	average	_
55-8	8372-8376	stop	_
55-9	8377-8383	signal	_
55-10	8384-8389	delay	_
55-11	8390-8392	at	_
55-12	8393-8398	which	_
55-13	8399-8411	participants	_
55-14	8412-8419	achieve	_
55-15	8420-8422	50	_
55-16	8423-8424	%	_
55-17	8425-8427	of	_
55-18	8428-8438	inhibition	_
55-19	8439-8443	from	_
55-20	8444-8447	the	_
55-21	8448-8455	average	_
55-22	8456-8464	reaction	_
55-23	8465-8469	time	_
55-24	8470-8472	to	_
55-25	8473-8475	go	_
55-26	8476-8483	signals	_
55-27	8484-8485	.	_

56-1	8486-8489	The	_
56-2	8490-8494	mean	_
56-3	8495-8498	and	_
56-4	8499-8507	standard	_
56-5	8508-8517	deviation	_
56-6	8518-8520	of	_
56-7	8521-8524	the	_
56-8	8525-8529	SSRT	_
56-9	8530-8533	for	_
56-10	8534-8538	each	_
56-11	8539-8541	of	_
56-12	8542-8545	the	_
56-13	8546-8549	two	_
56-14	8550-8556	groups	_
56-15	8557-8558	,	_
56-16	8559-8561	as	_
56-17	8562-8566	well	_
56-18	8567-8569	as	_
56-19	8570-8575	other	_
56-20	8576-8580	task	_
56-21	8581-8592	performance	_
56-22	8593-8601	measures	_
56-23	8602-8606	such	_
56-24	8607-8609	as	_
56-25	8610-8614	mean	_
56-26	8615-8623	response	_
56-27	8624-8628	time	_
56-28	8629-8631	to	_
56-29	8632-8634	Go	_
56-30	8635-8641	trials	_
56-31	8642-8643	(	_
56-32	8644-8647	MRT	_
56-33	8648-8649	)	_
56-34	8650-8651	,	_
56-35	8652-8656	stop	_
56-36	8657-8663	signal	_
56-37	8664-8669	delay	_
56-38	8670-8671	(	_
56-39	8672-8675	SSD	_
56-40	8676-8677	)	_
56-41	8678-8679	,	_
56-42	8680-8688	omission	_
56-43	8689-8699	percentage	_
56-44	8700-8702	to	_
56-45	8703-8705	Go	_
56-46	8706-8712	trials	_
56-47	8713-8714	,	_
56-48	8715-8718	and	_
56-49	8719-8729	inhibition	_
56-50	8730-8740	percentage	_
56-51	8741-8742	,	_
56-52	8743-8746	are	_
56-53	8747-8756	presented	_
56-54	8757-8759	in	_
56-55	8760-8765	Table	_
56-56	8766-8767	1	_
56-57	8768-8769	.	_

57-1	8770-8774	Data	_
57-2	8775-8785	processing	_
57-3	8786-8789	and	_
57-4	8790-8798	analysis	_
57-5	8799-8802	The	_
57-6	8803-8807	fMRI	_
57-7	8808-8812	time	_
57-8	8813-8819	series	_
57-9	8820-8824	data	_
57-10	8825-8829	were	_
57-11	8830-8839	realigned	_
57-12	8840-8841	(	_
57-13	8842-8858	motion-corrected	_
57-14	8859-8860	)	_
57-15	8861-8866	using	_
57-16	8867-8874	MCFLIRT	_
57-17	8875-8876	,	_
57-18	8877-8882	slice	_
57-19	8883-8887	time	_
57-20	8888-8897	corrected	_
57-21	8898-8899	,	_
57-22	8900-8909	resampled	_
57-23	8910-8911	,	_
57-24	8912-8915	and	_
57-25	8916-8926	normalized	_
57-26	8927-8931	into	_
57-27	8932-8940	standard	_
57-28	8941-8942	2	_
57-29	8943-8945	mm	_
57-30	8946-8947	×	_
57-31	8948-8949	2	_
57-32	8950-8952	mm	_
57-33	8953-8954	×	_
57-34	8955-8956	2	_
57-35	8957-8959	mm	_
57-36	8960-8963	MNI	_
57-37	8964-8969	space	_
57-38	8970-8971	(	_
57-39	8972-8974	91	_
57-40	8975-8976	×	_
57-41	8977-8980	109	_
57-42	8981-8982	×	_
57-43	8983-8985	91	_
57-44	8986-8992	matrix	_
57-45	8993-8994	)	_
57-46	8995-8998	for	_
57-47	8999-9002	all	_
57-48	9003-9005	of	_
57-49	9006-9009	the	_
57-50	9010-9017	volumes	_
57-51	9018-9019	,	_
57-52	9020-9025	using	_
57-53	9026-9029	FSL	_
57-54	9030-9031	(	_
57-55	9032-9036	http	_
57-56	9037-9038	:	_
57-57	9039-9059	//fsl.fmrib.ox.ac.uk	_
57-58	9060-9061	)	_
57-59	9062-9063	.	_

58-1	9064-9071	Spatial	_
58-2	9072-9081	smoothing	_
58-3	9082-9086	with	_
58-4	9087-9088	a	_
58-5	9089-9097	Gaussian	_
58-6	9098-9104	kernel	_
58-7	9105-9107	of	_
58-8	9108-9112	5-mm	_
58-9	9113-9123	full-width	_
58-10	9124-9126	at	_
58-11	9127-9139	half-maximum	_
58-12	9140-9141	(	_
58-13	9142-9146	FWHM	_
58-14	9147-9148	)	_
58-15	9149-9152	was	_
58-16	9153-9157	also	_
58-17	9158-9167	performed	_
58-18	9168-9169	.	_

59-1	9170-9171	A	_
59-2	9172-9173	2	_
59-3	9174-9176	mm	_
59-4	9177-9180	MNI	_
59-5	9181-9183	T1	_
59-6	9184-9189	brain	_
59-7	9190-9194	mask	_
59-8	9195-9198	was	_
59-9	9199-9206	applied	_
59-10	9207-9210	for	_
59-11	9211-9214	the	_
59-12	9215-9220	brain	_
59-13	9221-9231	extraction	_
59-14	9232-9233	.	_

60-1	9234-9241	Spatial	_
60-2	9242-9247	group	_
60-3	9248-9251	ICA	_
60-4	9252-9255	was	_
60-5	9256-9260	done	_
60-6	9261-9263	on	_
60-7	9264-9274	normalized	_
60-8	9275-9279	data	_
60-9	9280-9285	using	_
60-10	9286-9289	the	_
60-11	9290-9295	Group	_
60-12	9296-9299	ICA	_
60-13	9300-9302	of	_
60-14	9303-9307	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
60-15	9308-9309	(	_
60-16	9310-9314	GIFT	_
60-17	9315-9316	)	_
60-18	9317-9324	Toolbox	_
60-19	9325-9326	(	_
60-20	9327-9331	http	_
60-21	9332-9333	:	_
60-22	9334-9351	//mialab.mrn.org/	_
60-23	9352-9365	software/gift	_
60-24	9366-9367	)	_
60-25	9368-9369	.	_

61-1	9370-9373	The	_
61-2	9374-9380	number	_
61-3	9381-9383	of	_
61-4	9384-9395	independent	_
61-5	9396-9406	components	_
61-6	9407-9410	was	_
61-7	9411-9414	set	_
61-8	9415-9417	to	_
61-9	9418-9420	20	_
61-10	9421-9423	to	_
61-11	9424-9428	keep	_
61-12	9429-9432	the	_
61-13	9433-9439	number	_
61-14	9440-9442	or	_
61-15	9443-9446	ICs	_
61-16	9447-9457	manageable	_
61-17	9458-9459	.	_

62-1	9460-9466	Static	_
62-2	9467-9469	FC	_
62-3	9470-9473	and	_
62-4	9474-9477	DFC	_
62-5	9478-9486	analyses	_
62-6	9487-9491	were	_
62-7	9492-9496	done	_
62-8	9497-9502	using	_
62-9	9503-9504	a	_
62-10	9505-9517	MATLAB-based	_
62-11	9518-9527	graphical	_
62-12	9528-9532	user	_
62-13	9533-9542	interface	_
62-14	9543-9551	software	_
62-15	9552-9557	which	_
62-16	9558-9561	was	_
62-17	9562-9571	developed	_
62-18	9572-9580	in-house	_
62-19	9581-9584	and	_
62-20	9585-9588	was	_
62-21	9589-9594	based	_
62-22	9595-9597	on	_
62-23	9598-9600	an	_
62-24	9601-9608	earlier	_
62-25	9609-9613	work	_
62-26	9614-9616	by	_
62-27	9617-9618	.	_

63-1	9619-9631	Procedurally	_
63-2	9632-9635	the	_
63-3	9636-9641	Group	_
63-4	9642-9645	ICA	_
63-5	9646-9652	begins	_
63-6	9653-9655	by	_
63-7	9656-9664	reducing	_
63-8	9665-9668	the	_
63-9	9669-9672	ICs	_
63-10	9673-9675	to	_
63-11	9676-9678	be	_
63-12	9679-9688	evaluated	_
63-13	9689-9691	by	_
63-14	9692-9695	ICA	_
63-15	9696-9698	by	_
63-16	9699-9704	first	_
63-17	9705-9710	using	_
63-18	9711-9720	principal	_
63-19	9721-9730	component	_
63-20	9731-9739	analysis	_
63-21	9740-9741	(	_
63-22	9742-9745	PCA	_
63-23	9746-9747	)	_
63-24	9748-9750	in	_
63-25	9751-9754	two	_
63-26	9755-9761	stages	_
63-27	9762-9763	.	_

64-1	9764-9768	Each	_
64-2	9769-9780	participant	_
64-3	9781-9785	file	_
64-4	9786-9794	contains	_
64-5	9795-9798	384	_
64-6	9799-9803	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
64-7	9804-9808	time	_
64-8	9809-9815	points	_
64-9	9816-9817	.	_

65-1	9818-9821	The	_
65-2	9822-9827	first	_
65-3	9828-9833	stage	_
65-4	9834-9841	reduced	_
65-5	9842-9846	each	_
65-6	9847-9849	of	_
65-7	9850-9853	the	_
65-8	9854-9856	83	_
65-9	9857-9869	participants	_
65-10	9870-9874	with	_
65-11	9875-9878	384	_
65-12	9879-9883	BOLD	_
65-13	9884-9888	fMRI	_
65-14	9889-9893	time	_
65-15	9894-9900	points	_
65-16	9901-9903	to	_
65-17	9904-9906	83	_
65-18	9907-9919	participants	_
65-19	9920-9921	,	_
65-20	9922-9926	each	_
65-21	9927-9931	with	_
65-22	9932-9934	20	_
65-23	9935-9938	ICs	_
65-24	9939-9940	.	_

66-1	9941-9944	The	_
66-2	9945-9951	second	_
66-3	9952-9957	stage	_
66-4	9958-9960	of	_
66-5	9961-9964	PCA	_
66-6	9965-9972	reduced	_
66-7	9973-9977	this	_
66-8	9978-9983	group	_
66-9	9984-9986	to	_
66-10	9987-9988	a	_
66-11	9989-9995	single	_
66-12	9996-10001	group	_
66-13	10002-10004	of	_
66-14	10005-10007	20	_
66-15	10008-10011	ICs	_
66-16	10012-10015	for	_
66-17	10016-10019	the	_
66-18	10020-10032	participants	_
66-19	10033-10040	grouped	_
66-20	10041-10049	together	_
66-21	10050-10051	.	_

67-1	10052-10056	This	_
67-2	10057-10062	final	_
67-3	10063-10068	group	_
67-4	10069-10071	is	_
67-5	10072-10081	evaluated	_
67-6	10082-10086	with	_
67-7	10087-10094	InfoMax	_
67-8	10095-10098	ICA	_
67-9	10099-10100	.	_

68-1	10101-10108	InfoMax	_
68-2	10109-10112	ICA	_
68-3	10113-10116	was	_
68-4	10117-10122	setup	_
68-5	10123-10127	with	_
68-6	10128-10132	bias	_
68-7	10133-10136	and	_
68-8	10137-10145	sphering	_
68-9	10146-10148	on	_
68-10	10149-10150	.	_

69-1	10151-10156	Block	_
69-2	10157-10161	size	_
69-3	10162-10163	,	_
69-4	10164-10168	stop	_
69-5	10169-10170	,	_
69-6	10171-10176	Irate	_
69-7	10177-10178	,	_
69-8	10179-10182	max	_
69-9	10183-10187	step	_
69-10	10188-10189	,	_
69-11	10190-10196	anneal	_
69-12	10197-10198	,	_
69-13	10199-10202	and	_
69-14	10203-10209	anneal	_
69-15	10210-10215	angle	_
69-16	10216-10220	were	_
69-17	10221-10224	set	_
69-18	10225-10227	to	_
69-19	10228-10235	default	_
69-20	10236-10242	values	_
69-21	10243-10245	of	_
69-22	10246-10249	275	_
69-23	10250-10251	,	_
69-24	10252-10253	1	_
69-25	10254-10255	×	_
69-26	10256-10259	106	_
69-27	10260-10261	,	_
69-28	10262-10271	0.0050071	_
69-29	10272-10273	,	_
69-30	10274-10277	512	_
69-31	10278-10279	,	_
69-32	10280-10283	0.9	_
69-33	10284-10285	,	_
69-34	10286-10289	and	_
69-35	10290-10292	60	_
69-36	10293-10300	degrees	_
69-37	10301-10302	,	_
69-38	10303-10315	respectively	_
69-39	10316-10317	.	_

70-1	10318-10321	The	_
70-2	10322-10329	results	_
70-3	10330-10333	are	_
70-4	10334-10338	then	_
70-5	10339-10343	back	_
70-6	10344-10357	reconstructed	_
70-7	10358-10361	for	_
70-8	10362-10366	each	_
70-9	10367-10369	of	_
70-10	10370-10373	the	_
70-11	10374-10376	83	_
70-12	10377-10389	participants	_
70-13	10390-10391	,	_
70-14	10392-10396	each	_
70-15	10397-10401	with	_
70-16	10402-10404	20	_
70-17	10405-10408	ICs	_
70-18	10409-10412	and	_
70-19	10413-10415	an	_
70-20	10416-10428	accompanying	_
70-21	10429-10433	time	_
70-22	10434-10440	course	_
70-23	10441-10444	for	_
70-24	10445-10449	each	_
70-25	10450-10452	IC	_
70-26	10453-10454	.	_

71-1	10455-10460	After	_
71-2	10461-10469	detailed	_
71-3	10470-10476	visual	_
71-4	10477-10487	inspection	_
71-5	10488-10489	,	_
71-6	10490-10492	12	_
71-7	10493-10495	of	_
71-8	10496-10499	the	_
71-9	10500-10502	20	_
71-10	10503-10506	ICs	_
71-11	10507-10511	were	_
71-12	10512-10517	found	_
71-13	10518-10520	to	_
71-14	10521-10523	be	_
71-15	10524-10535	artifactual	_
71-16	10536-10538	or	_
71-17	10539-10550	nonrelevant	_
71-18	10551-10561	components	_
71-19	10562-10563	;	_
71-20	10564-10573	therefore	_
71-21	10574-10575	,	_
71-22	10576-10579	the	_
71-23	10580-10586	number	_
71-24	10587-10589	of	_
71-25	10590-10598	relevant	_
71-26	10599-10602	ICs	_
71-27	10603-10607	were	_
71-28	10608-10615	reduced	_
71-29	10616-10618	to	_
71-30	10619-10620	8	_
71-31	10621-10622	,	_
71-32	10623-10628	which	_
71-33	10629-10639	constitute	_
71-34	10640-10643	the	_
71-35	10644-10652	relevant	_
71-36	10653-10658	brain	_
71-37	10659-10667	networks	_
71-38	10668-10671	for	_
71-39	10672-10675	our	_
71-40	10676-10684	analysis	_
71-41	10685-10686	.	_

72-1	10687-10693	Static	_
72-2	10694-10696	FC	_
72-3	10697-10704	between	_
72-4	10705-10708	any	_
72-5	10709-10712	two	_
72-6	10713-10716	ICs	_
72-7	10717-10720	was	_
72-8	10721-10729	measured	_
72-9	10730-10732	by	_
72-10	10733-10744	calculating	_
72-11	10745-10748	the	_
72-12	10749-10751	2D	_
72-13	10752-10763	correlation	_
72-14	10764-10771	between	_
72-15	10772-10775	the	_
72-16	10776-10780	time	_
72-17	10781-10788	courses	_
72-18	10789-10791	of	_
72-19	10792-10795	the	_
72-20	10796-10799	two	_
72-21	10800-10803	ICs	_
72-22	10804-10805	.	_

73-1	10806-10809	The	_
73-2	10810-10816	result	_
73-3	10817-10819	is	_
73-4	10820-10821	a	_
73-5	10822-10828	single	_
73-6	10829-10846	cross-correlation	_
73-7	10847-10858	coefficient	_
73-8	10859-10860	(	_
73-9	10861-10863	cc	_
73-10	10864-10865	)	_
73-11	10866-10867	,	_
73-12	10868-10873	which	_
73-13	10874-10881	reveals	_
73-14	10882-10885	how	_
73-15	10886-10892	strong	_
73-16	10893-10896	the	_
73-17	10897-10907	connection	_
73-18	10908-10910	is	_
73-19	10911-10918	between	_
73-20	10919-10922	the	_
73-21	10923-10926	two	_
73-22	10927-10930	ICs	_
73-23	10931-10932	.	_

74-1	10933-10934	A	_
74-2	10935-10941	matrix	_
74-3	10942-10944	of	_
74-4	10945-10947	cc	_
74-5	10948-10954	values	_
74-6	10955-10957	is	_
74-7	10958-10967	generated	_
74-8	10968-10970	by	_
74-9	10971-10982	calculating	_
74-10	10983-10986	the	_
74-11	10987-10989	2D	_
74-12	10990-11001	correlation	_
74-13	11002-11005	for	_
74-14	11006-11009	all	_
74-15	11010-11012	IC	_
74-16	11013-11016	and	_
74-17	11017-11028	participant	_
74-18	11029-11041	combinations	_
74-19	11042-11043	.	_

75-1	11044-11053	Therefore	_
75-2	11054-11055	,	_
75-3	11056-11060	with	_
75-4	11061-11063	83	_
75-5	11064-11076	participants	_
75-6	11077-11078	,	_
75-7	11079-11080	8	_
75-8	11081-11084	ICs	_
75-9	11085-11088	and	_
75-10	11089-11091	28	_
75-11	11092-11099	IC-pair	_
75-12	11100-11112	combinations	_
75-13	11113-11114	,	_
75-14	11115-11116	a	_
75-15	11117-11123	matrix	_
75-16	11124-11128	with	_
75-17	11129-11131	83	_
75-18	11132-11136	rows	_
75-19	11137-11140	and	_
75-20	11141-11143	28	_
75-21	11144-11151	columns	_
75-22	11152-11154	is	_
75-23	11155-11164	generated	_
75-24	11165-11166	.	_

76-1	11167-11173	Column	_
76-2	11174-11180	labels	_
76-3	11181-11185	were	_
76-4	11186-11191	added	_
76-5	11192-11194	to	_
76-6	11195-11198	the	_
76-7	11199-11203	data	_
76-8	11204-11206	to	_
76-9	11207-11215	identify	_
76-10	11216-11219	the	_
76-11	11220-11222	IC	_
76-12	11223-11235	combinations	_
76-13	11236-11239	the	_
76-14	11240-11244	data	_
76-15	11245-11253	belonged	_
76-16	11254-11256	to	_
76-17	11257-11258	.	_

77-1	11259-11262	Row	_
77-2	11263-11269	labels	_
77-3	11270-11274	were	_
77-4	11275-11280	added	_
77-5	11281-11283	to	_
77-6	11284-11292	identify	_
77-7	11293-11298	which	_
77-8	11299-11304	group	_
77-9	11305-11306	(	_
77-10	11307-11314	control	_
77-11	11315-11317	or	_
77-12	11318-11320	CD	_
77-13	11321-11322	)	_
77-14	11323-11327	each	_
77-15	11328-11339	participant	_
77-16	11340-11348	belonged	_
77-17	11349-11351	to	_
77-18	11352-11353	.	_

78-1	11354-11358	This	_
78-2	11359-11365	static	_
78-3	11366-11368	FC	_
78-4	11369-11375	matrix	_
78-5	11376-11378	is	_
78-6	11379-11383	then	_
78-7	11384-11388	used	_
78-8	11389-11392	for	_
78-9	11393-11407	classification	_
78-10	11408-11415	between	_
78-11	11416-11423	control	_
78-12	11424-11427	and	_
78-13	11428-11430	CD	_
78-14	11431-11432	.	_

79-1	11433-11436	The	_
79-2	11437-11443	method	_
79-3	11444-11448	used	_
79-4	11449-11451	to	_
79-5	11452-11461	calculate	_
79-6	11462-11465	DFC	_
79-7	11466-11469	was	_
79-8	11470-11472	by	_
79-9	11473-11481	sweeping	_
79-10	11482-11483	a	_
79-11	11484-11488	time	_
79-12	11489-11495	window	_
79-13	11496-11502	across	_
79-14	11503-11504	a	_
79-15	11505-11509	time	_
79-16	11510-11516	course	_
79-17	11517-11518	(	_
79-18	11519-11525	Figure	_
79-19	11526-11527	2	_
79-20	11528-11529	)	_
79-21	11530-11531	.	_

80-1	11532-11535	All	_
80-2	11536-11542	points	_
80-3	11543-11547	from	_
80-4	11548-11552	each	_
80-5	11553-11557	time	_
80-6	11558-11564	course	_
80-7	11565-11569	that	_
80-8	11570-11573	are	_
80-9	11574-11580	inside	_
80-10	11581-11584	the	_
80-11	11585-11592	sliding	_
80-12	11593-11599	window	_
80-13	11600-11609	rectangle	_
80-14	11610-11613	are	_
80-15	11614-11618	used	_
80-16	11619-11621	in	_
80-17	11622-11625	the	_
80-18	11626-11628	2D	_
80-19	11629-11640	correlation	_
80-20	11641-11643	to	_
80-21	11644-11651	produce	_
80-22	11652-11653	a	_
80-23	11654-11660	single	_
80-24	11661-11678	cross-correlation	_
80-25	11679-11690	coefficient	_
80-26	11691-11692	(	_
80-27	11693-11695	cc	_
80-28	11696-11697	)	_
80-29	11698-11699	.	_

81-1	11700-11703	For	_
81-2	11704-11708	each	_
81-3	11709-11720	participant	_
81-4	11721-11722	,	_
81-5	11723-11732	pair-wise	_
81-6	11733-11740	regions	_
81-7	11741-11744	are	_
81-8	11745-11755	determined	_
81-9	11756-11759	and	_
81-10	11760-11765	their	_
81-11	11766-11770	fMRI	_
81-12	11771-11775	time	_
81-13	11776-11783	courses	_
81-14	11784-11787	are	_
81-15	11788-11796	recorded	_
81-16	11797-11799	in	_
81-17	11800-11803	two	_
81-18	11804-11822	single-dimensional	_
81-19	11823-11829	arrays	_
81-20	11830-11831	.	_

82-1	11832-11835	Two	_
82-2	11836-11846	parameters	_
82-3	11847-11851	were	_
82-4	11852-11860	required	_
82-5	11861-11862	:	_
82-6	11863-11869	window	_
82-7	11870-11874	size	_
82-8	11875-11878	and	_
82-9	11879-11885	window	_
82-10	11886-11890	step	_
82-11	11891-11895	size	_
82-12	11896-11897	.	_

83-1	11898-11909	Correlation	_
83-2	11910-11922	coefficients	_
83-3	11923-11925	of	_
83-4	11926-11929	the	_
83-5	11930-11939	resulting	_
83-6	11940-11943	DFC	_
83-7	11944-11945	,	_
83-8	11946-11951	which	_
83-9	11952-11954	is	_
83-10	11955-11959	also	_
83-11	11960-11961	a	_
83-12	11962-11969	dynamic	_
83-13	11970-11974	time	_
83-14	11975-11981	series	_
83-15	11982-11986	data	_
83-16	11987-11988	,	_
83-17	11989-11992	are	_
83-18	11993-12003	calculated	_
83-19	12004-12007	for	_
83-20	12008-12012	each	_
83-21	12013-12015	of	_
83-22	12016-12019	the	_
83-23	12020-12028	windowed	_
83-24	12029-12033	time	_
83-25	12034-12041	courses	_
83-26	12042-12044	of	_
83-27	12045-12049	each	_
83-28	12050-12052	IC	_
83-29	12053-12057	pair	_
83-30	12058-12059	,	_
83-31	12060-12062	at	_
83-32	12063-12068	every	_
83-33	12069-12075	window	_
83-34	12076-12080	step	_
83-35	12081-12082	.	_

84-1	12083-12087	Each	_
84-2	12088-12090	IC	_
84-3	12091-12094	for	_
84-4	12095-12099	each	_
84-5	12100-12102	of	_
84-6	12103-12106	the	_
84-7	12107-12119	participants	_
84-8	12120-12123	has	_
84-9	12124-12125	a	_
84-10	12126-12139	corresponding	_
84-11	12140-12144	time	_
84-12	12145-12151	course	_
84-13	12152-12153	,	_
84-14	12154-12157	and	_
84-15	12158-12165	thereby	_
84-16	12166-12169	the	_
84-17	12170-12174	time	_
84-18	12175-12183	coursers	_
84-19	12184-12188	were	_
84-20	12189-12198	extracted	_
84-21	12199-12203	from	_
84-22	12204-12207	the	_
84-23	12208-12211	ICA	_
84-24	12212-12213	’	_
84-25	12214-12215	s	_
84-26	12216-12228	computations	_
84-27	12229-12230	,	_
84-28	12231-12234	for	_
84-29	12235-12238	the	_
84-30	12239-12241	IC	_
84-31	12242-12243	’	_
84-32	12244-12245	s	_
84-33	12246-12248	of	_
84-34	12249-12257	interest	_
84-35	12258-12259	(	_
84-36	12260-12263	the	_
84-37	12264-12268	ones	_
84-38	12269-12273	that	_
84-39	12274-12277	are	_
84-40	12278-12284	deemed	_
84-41	12285-12287	to	_
84-42	12288-12297	represent	_
84-43	12298-12308	meaningful	_
84-44	12309-12314	brain	_
84-45	12315-12323	networks	_
84-46	12324-12325	,	_
84-47	12326-12329	not	_
84-48	12330-12339	artifacts	_
84-49	12340-12341	)	_
84-50	12342-12343	.	_

85-1	12344-12354	Throughout	_
85-2	12355-12359	this	_
85-3	12360-12365	paper	_
85-4	12366-12367	,	_
85-5	12368-12371	the	_
85-6	12372-12383	calculation	_
85-7	12384-12386	of	_
85-8	12387-12390	DFC	_
85-9	12391-12402	correlation	_
85-10	12403-12415	coefficients	_
85-11	12416-12420	from	_
85-12	12421-12424	two	_
85-13	12425-12429	time	_
85-14	12430-12437	courses	_
85-15	12438-12440	is	_
85-16	12441-12451	considered	_
85-17	12452-12455	the	_
85-18	12456-12464	smallest	_
85-19	12465-12476	calculation	_
85-20	12477-12481	unit	_
85-21	12482-12484	of	_
85-22	12485-12488	the	_
85-23	12489-12492	DFC	_
85-24	12493-12501	analyses	_
85-25	12502-12503	.	_

86-1	12504-12506	In	_
86-2	12507-12514	general	_
86-3	12515-12516	,	_
86-4	12517-12521	once	_
86-5	12522-12525	the	_
86-6	12526-12530	time	_
86-7	12531-12538	courses	_
86-8	12539-12542	are	_
86-9	12543-12552	extracted	_
86-10	12553-12554	(	_
86-11	12555-12558	via	_
86-12	12559-12562	ICA	_
86-13	12563-12565	or	_
86-14	12566-12575	otherwise	_
86-15	12576-12577	,	_
86-16	12578-12582	such	_
86-17	12583-12585	as	_
86-18	12586-12595	ROI-based	_
86-19	12596-12603	average	_
86-20	12604-12608	time	_
86-21	12609-12615	course	_
86-22	12616-12626	extraction	_
86-23	12627-12628	)	_
86-24	12629-12630	,	_
86-25	12631-12634	DFC	_
86-26	12635-12643	analyses	_
86-27	12644-12655	investigate	_
86-28	12656-12668	interactions	_
86-29	12669-12674	among	_
86-30	12675-12680	brain	_
86-31	12681-12689	networks	_
86-32	12690-12692	or	_
86-33	12693-12700	regions	_
86-34	12701-12706	using	_
86-35	12707-12714	sliding	_
86-36	12715-12721	window	_
86-37	12722-12733	correlation	_
86-38	12734-12735	.	_

87-1	12736-12739	The	_
87-2	12740-12747	outcome	_
87-3	12748-12750	of	_
87-4	12751-12754	DFC	_
87-5	12755-12763	analysis	_
87-6	12764-12771	between	_
87-7	12772-12775	two	_
87-8	12776-12784	networks	_
87-9	12785-12787	or	_
87-10	12788-12793	brain	_
87-11	12794-12801	regions	_
87-12	12802-12804	is	_
87-13	12805-12809	also	_
87-14	12810-12817	another	_
87-15	12818-12822	time	_
87-16	12823-12829	course	_
87-17	12830-12834	that	_
87-18	12835-12845	summarizes	_
87-19	12846-12854	dynamics	_
87-20	12855-12862	between	_
87-21	12863-12866	the	_
87-22	12867-12874	regions	_
87-23	12875-12877	of	_
87-24	12878-12886	interest	_
87-25	12887-12888	.	_

88-1	12889-12891	At	_
88-2	12892-12895	the	_
88-3	12896-12899	end	_
88-4	12900-12901	,	_
88-5	12902-12906	this	_
88-6	12907-12913	method	_
88-7	12914-12924	identified	_
88-8	12925-12930	pairs	_
88-9	12931-12933	of	_
88-10	12934-12939	brain	_
88-11	12940-12945	areas	_
88-12	12946-12950	that	_
88-13	12951-12954	are	_
88-14	12955-12966	interacting	_
88-15	12967-12975	together	_
88-16	12976-12979	and	_
88-17	12980-12983	the	_
88-18	12984-12992	dynamics	_
88-19	12993-12995	of	_
88-20	12996-12999	the	_
88-21	13000-13011	interaction	_
88-22	13012-13013	.	_

89-1	13014-13017	The	_
89-2	13018-13021	DFC	_
89-3	13022-13029	between	_
89-4	13030-13033	two	_
89-5	13034-13039	brain	_
89-6	13040-13048	networks	_
89-7	13049-13051	or	_
89-8	13052-13059	regions	_
89-9	13060-13062	is	_
89-10	13063-13073	summarized	_
89-11	13074-13076	in	_
89-12	13077-13083	Figure	_
89-13	13084-13085	2	_
89-14	13086-13087	.	_

90-1	13088-13090	In	_
90-2	13091-13094	our	_
90-3	13095-13099	case	_
90-4	13100-13101	,	_
90-5	13102-13104	we	_
90-6	13105-13115	determined	_
90-7	13116-13119	the	_
90-8	13120-13125	brain	_
90-9	13126-13134	networks	_
90-10	13135-13138	via	_
90-11	13139-13142	ICA	_
90-12	13143-13144	.	_

91-1	13145-13149	More	_
91-2	13150-13157	details	_
91-3	13158-13160	on	_
91-4	13161-13164	the	_
91-5	13165-13176	methodology	_
91-6	13177-13179	of	_
91-7	13180-13183	the	_
91-8	13184-13187	DFC	_
91-9	13188-13191	can	_
91-10	13192-13194	be	_
91-11	13195-13200	found	_
91-12	13201-13203	in	_
91-13	13204-13205	.	_

92-1	13206-13208	In	_
92-2	13209-13212	our	_
92-3	13213-13218	study	_
92-4	13219-13220	,	_
92-5	13221-13224	the	_
92-6	13225-13229	size	_
92-7	13230-13232	of	_
92-8	13233-13236	the	_
92-9	13237-13244	sliding	_
92-10	13245-13251	window	_
92-11	13252-13254	is	_
92-12	13255-13257	32	_
92-13	13258-13262	time	_
92-14	13263-13269	points	_
92-15	13270-13271	.	_

93-1	13272-13276	With	_
93-2	13277-13278	a	_
93-3	13279-13281	TR	_
93-4	13282-13283	=	_
93-5	13284-13287	1.7	_
93-6	13288-13289	s	_
93-7	13290-13291	,	_
93-8	13292-13295	the	_
93-9	13296-13300	time	_
93-10	13301-13307	window	_
93-11	13308-13310	is	_
93-12	13311-13315	54.4	_
93-13	13316-13317	s	_
93-14	13318-13322	wide	_
93-15	13323-13324	.	_

94-1	13325-13329	Each	_
94-2	13330-13334	time	_
94-3	13335-13338	the	_
94-4	13339-13345	window	_
94-5	13346-13351	steps	_
94-6	13352-13358	across	_
94-7	13359-13362	the	_
94-8	13363-13366	TCs	_
94-9	13367-13368	,	_
94-10	13369-13370	8	_
94-11	13371-13375	time	_
94-12	13376-13382	points	_
94-13	13383-13386	are	_
94-14	13387-13393	jumped	_
94-15	13394-13398	over	_
94-16	13399-13400	(	_
94-17	13401-13407	window	_
94-18	13408-13412	step	_
94-19	13413-13417	size	_
94-20	13418-13420	of	_
94-21	13421-13422	8	_
94-22	13423-13424	)	_
94-23	13425-13426	,	_
94-24	13427-13432	which	_
94-25	13433-13444	corresponds	_
94-26	13445-13447	to	_
94-27	13448-13449	a	_
94-28	13450-13454	13.6	_
94-29	13455-13457	s.	_
94-30	13458-13460	We	_
94-31	13461-13466	chose	_
94-32	13467-13470	the	_
94-33	13471-13475	size	_
94-34	13476-13478	of	_
94-35	13479-13481	32	_
94-36	13482-13485	for	_
94-37	13486-13489	the	_
94-38	13490-13497	sliding	_
94-39	13498-13504	window	_
94-40	13505-13510	since	_
94-41	13511-13514	one	_
94-42	13515-13520	needs	_
94-43	13521-13522	n	_
94-44	13523-13524	>	_
94-45	13525-13527	30	_
94-46	13528-13532	data	_
94-47	13533-13539	points	_
94-48	13540-13542	in	_
94-49	13543-13548	order	_
94-50	13549-13551	to	_
94-51	13552-13558	obtain	_
94-52	13559-13560	a	_
94-53	13561-13569	reliable	_
94-54	13570-13581	correlation	_
94-55	13582-13593	coefficient	_
94-56	13594-13607	statistically	_
94-57	13608-13609	(	_
94-58	13610-13613	for	_
94-59	13614-13615	n	_
94-60	13616-13617	>	_
94-61	13618-13620	30	_
94-62	13621-13628	samples	_
94-63	13629-13630	,	_
94-64	13631-13634	the	_
94-65	13635-13649	t-distribution	_
94-66	13650-13653	and	_
94-67	13654-13657	the	_
94-68	13658-13664	Normal	_
94-69	13665-13677	distribution	_
94-70	13678-13681	are	_
94-71	13682-13686	very	_
94-72	13687-13694	similar	_
94-73	13695-13696	)	_
94-74	13697-13698	.	_

95-1	13699-13705	Choice	_
95-2	13706-13708	of	_
95-3	13709-13710	8	_
95-4	13711-13714	for	_
95-5	13715-13718	the	_
95-6	13719-13725	window	_
95-7	13726-13730	step	_
95-8	13731-13735	size	_
95-9	13736-13739	was	_
95-10	13740-13748	somewhat	_
95-11	13749-13758	arbitrary	_
95-12	13759-13760	;	_
95-13	13761-13763	we	_
95-14	13764-13770	wanted	_
95-15	13771-13773	to	_
95-16	13774-13778	keep	_
95-17	13779-13780	a	_
95-18	13781-13788	balance	_
95-19	13789-13796	between	_
95-20	13797-13803	having	_
95-21	13804-13807	too	_
95-22	13808-13813	short	_
95-23	13814-13816	of	_
95-24	13817-13818	a	_
95-25	13819-13823	step	_
95-26	13824-13828	size	_
95-27	13829-13830	(	_
95-28	13831-13836	which	_
95-29	13837-13842	would	_
95-30	13843-13851	probably	_
95-31	13852-13855	not	_
95-32	13856-13863	capture	_
95-33	13864-13867	any	_
95-34	13868-13872	real	_
95-35	13873-13876	DFC	_
95-36	13877-13884	changes	_
95-37	13885-13888	but	_
95-38	13889-13897	probably	_
95-39	13898-13904	mostly	_
95-40	13905-13910	noise	_
95-41	13911-13912	)	_
95-42	13913-13916	and	_
95-43	13917-13920	too	_
95-44	13921-13925	long	_
95-45	13926-13927	(	_
95-46	13928-13933	which	_
95-47	13934-13939	could	_
95-48	13940-13944	miss	_
95-49	13945-13948	any	_
95-50	13949-13953	real	_
95-51	13954-13957	DFC	_
95-52	13958-13965	changes	_
95-53	13966-13967	)	_
95-54	13968-13969	.	_

96-1	13970-13972	We	_
96-2	13973-13980	discuss	_
96-3	13981-13984	the	_
96-4	13985-13992	effects	_
96-5	13993-13995	of	_
96-6	13996-13999	our	_
96-7	14000-14006	window	_
96-8	14007-14011	size	_
96-9	14012-14015	and	_
96-10	14016-14019	the	_
96-11	14020-14026	window	_
96-12	14027-14031	step	_
96-13	14032-14036	size	_
96-14	14037-14041	more	_
96-15	14042-14044	in	_
96-16	14045-14048	the	_
96-17	14049-14059	Discussion	_
96-18	14060-14067	section	_
96-19	14068-14069	.	_

97-1	14070-14072	In	_
97-2	14073-14076	our	_
97-3	14077-14081	case	_
97-4	14082-14083	,	_
97-5	14084-14089	since	_
97-6	14090-14095	there	_
97-7	14096-14099	are	_
97-8	14100-14103	384	_
97-9	14104-14109	total	_
97-10	14110-14114	time	_
97-11	14115-14121	points	_
97-12	14122-14123	,	_
97-13	14124-14126	as	_
97-14	14127-14128	a	_
97-15	14129-14135	result	_
97-16	14136-14137	,	_
97-17	14138-14141	the	_
97-18	14142-14145	DFC	_
97-19	14146-14154	analysis	_
97-20	14155-14162	results	_
97-21	14163-14165	in	_
97-22	14166-14168	45	_
97-23	14169-14171	cc	_
97-24	14172-14178	values	_
97-25	14179-14180	.	_

98-1	14181-14186	There	_
98-2	14187-14190	are	_
98-3	14191-14193	28	_
98-4	14194-14201	pairing	_
98-5	14202-14214	combinations	_
98-6	14215-14222	between	_
98-7	14223-14224	8	_
98-8	14225-14228	ICs	_
98-9	14229-14230	.	_

99-1	14231-14240	Therefore	_
99-2	14241-14242	,	_
99-3	14243-14247	with	_
99-4	14248-14250	83	_
99-5	14251-14263	participants	_
99-6	14264-14265	,	_
99-7	14266-14267	8	_
99-8	14268-14271	ICs	_
99-9	14272-14273	,	_
99-10	14274-14276	28	_
99-11	14277-14279	IC	_
99-12	14280-14285	pairs	_
99-13	14286-14287	,	_
99-14	14288-14291	and	_
99-15	14292-14294	45	_
99-16	14295-14297	cc	_
99-17	14298-14304	values	_
99-18	14305-14308	per	_
99-19	14309-14311	IC	_
99-20	14312-14323	combination	_
99-21	14324-14325	,	_
99-22	14326-14327	a	_
99-23	14328-14334	matrix	_
99-24	14335-14339	with	_
99-25	14340-14342	83	_
99-26	14343-14347	rows	_
99-27	14348-14351	and	_
99-28	14352-14357	1,260	_
99-29	14358-14365	columns	_
99-30	14366-14369	was	_
99-31	14370-14379	generated	_
99-32	14380-14381	.	_

100-1	14382-14388	Column	_
100-2	14389-14395	labels	_
100-3	14396-14400	were	_
100-4	14401-14406	added	_
100-5	14407-14409	to	_
100-6	14410-14413	the	_
100-7	14414-14418	data	_
100-8	14419-14421	to	_
100-9	14422-14430	identify	_
100-10	14431-14434	the	_
100-11	14435-14437	IC	_
100-12	14438-14449	combination	_
100-13	14450-14454	that	_
100-14	14455-14458	the	_
100-15	14459-14463	data	_
100-16	14464-14472	belonged	_
100-17	14473-14475	to	_
100-18	14476-14478	as	_
100-19	14479-14483	well	_
100-20	14484-14486	as	_
100-21	14487-14490	the	_
100-22	14491-14496	order	_
100-23	14497-14503	number	_
100-24	14504-14506	of	_
100-25	14507-14510	the	_
100-26	14511-14513	cc	_
100-27	14514-14515	.	_

101-1	14516-14519	Row	_
101-2	14520-14526	labels	_
101-3	14527-14531	were	_
101-4	14532-14537	added	_
101-5	14538-14540	to	_
101-6	14541-14549	identify	_
101-7	14550-14555	which	_
101-8	14556-14561	group	_
101-9	14562-14563	(	_
101-10	14564-14572	controls	_
101-11	14573-14575	or	_
101-12	14576-14578	CD	_
101-13	14579-14580	)	_
101-14	14581-14585	each	_
101-15	14586-14597	participant	_
101-16	14598-14606	belonged	_
101-17	14607-14609	to	_
101-18	14610-14611	.	_

102-1	14612-14616	This	_
102-2	14617-14620	DFC	_
102-3	14621-14623	cc	_
102-4	14624-14630	matrix	_
102-5	14631-14634	was	_
102-6	14635-14639	then	_
102-7	14640-14644	used	_
102-8	14645-14648	for	_
102-9	14649-14663	classification	_
102-10	14664-14671	between	_
102-11	14672-14680	controls	_
102-12	14681-14684	and	_
102-13	14685-14687	CD	_
102-14	14688-14689	.	_

103-1	14690-14700	Anatomical	_
103-2	14701-14715	identification	_
103-3	14716-14718	of	_
103-4	14719-14722	the	_
103-5	14723-14734	independent	_
103-6	14735-14745	components	_
103-7	14746-14756	Anatomical	_
103-8	14757-14771	identification	_
103-9	14772-14774	of	_
103-10	14775-14778	the	_
103-11	14779-14782	ICs	_
103-12	14783-14786	was	_
103-13	14787-14796	performed	_
103-14	14797-14802	using	_
103-15	14803-14806	the	_
103-16	14807-14821	Harvard-Oxford	_
103-17	14822-14827	brain	_
103-18	14828-14833	atlas	_
103-19	14834-14836	in	_
103-20	14837-14842	order	_
103-21	14843-14845	to	_
103-22	14846-14855	determine	_
103-23	14856-14861	which	_
103-24	14862-14872	anatomical	_
103-25	14873-14878	brain	_
103-26	14879-14886	regions	_
103-27	14887-14891	that	_
103-28	14892-14895	had	_
103-29	14896-14899	the	_
103-30	14900-14904	most	_
103-31	14905-14913	coverage	_
103-32	14914-14916	by	_
103-33	14917-14921	each	_
103-34	14922-14924	IC	_
103-35	14925-14926	.	_

104-1	14927-14930	The	_
104-2	14931-14940	procedure	_
104-3	14941-14946	which	_
104-4	14947-14949	is	_
104-5	14950-14954	used	_
104-6	14955-14957	to	_
104-7	14958-14963	score	_
104-8	14964-14967	the	_
104-9	14968-14976	coverage	_
104-10	14977-14979	of	_
104-11	14980-14984	each	_
104-12	14985-14990	atlas	_
104-13	14991-14997	region	_
104-14	14998-15000	by	_
104-15	15001-15003	an	_
104-16	15004-15006	IC	_
104-17	15007-15014	network	_
104-18	15015-15017	is	_
104-19	15018-15027	described	_
104-20	15028-15030	in	_
104-21	15031-15034	the	_
104-22	15035-15045	pseudocode	_
104-23	15046-15051	shown	_
104-24	15052-15054	in	_
104-25	15055-15060	Table	_
104-26	15061-15062	2	_
104-27	15063-15064	.	_

105-1	15065-15067	In	_
105-2	15068-15072	this	_
105-3	15073-15080	process	_
105-4	15081-15082	,	_
105-5	15083-15085	we	_
105-6	15086-15095	calculate	_
105-7	15096-15110	regionCoverage	_
105-8	15111-15112	,	_
105-9	15113-15118	which	_
105-10	15119-15121	is	_
105-11	15122-15125	the	_
105-12	15126-15133	percent	_
105-13	15134-15142	coverage	_
105-14	15143-15145	of	_
105-15	15146-15149	the	_
105-16	15150-15156	region	_
105-17	15157-15159	by	_
105-18	15160-15163	the	_
105-19	15164-15166	IC	_
105-20	15167-15168	.	_

106-1	15169-15173	Only	_
106-2	15174-15177	ICA	_
106-3	15178-15184	voxels	_
106-4	15185-15188	for	_
106-5	15189-15194	which	_
106-6	15195-15198	the	_
106-7	15199-15207	absolute	_
106-8	15208-15213	value	_
106-9	15214-15221	Z-score	_
106-10	15222-15224	is	_
106-11	15225-15232	greater	_
106-12	15233-15237	than	_
106-13	15238-15241	1.7	_
106-14	15242-15249	qualify	_
106-15	15250-15252	as	_
106-16	15253-15259	region	_
106-17	15260-15268	covering	_
106-18	15269-15275	voxels	_
106-19	15276-15277	.	_

107-1	15278-15281	The	_
107-2	15282-15287	value	_
107-3	15288-15290	of	_
107-4	15291-15294	1.7	_
107-5	15295-15304	indicates	_
107-6	15305-15309	that	_
107-7	15310-15313	the	_
107-8	15314-15319	voxel	_
107-9	15320-15322	is	_
107-10	15323-15329	beyond	_
107-11	15330-15332	99	_
107-12	15333-15334	%	_
107-13	15335-15337	of	_
107-14	15338-15341	the	_
107-15	15342-15349	Z-score	_
107-16	15350-15362	distribution	_
107-17	15363-15364	.	_

108-1	15365-15368	For	_
108-2	15369-15372	the	_
108-3	15373-15387	Harvard-Oxford	_
108-4	15388-15393	atlas	_
108-5	15394-15395	,	_
108-6	15396-15399	the	_
108-7	15400-15406	values	_
108-8	15407-15414	outside	_
108-9	15415-15418	the	_
108-10	15419-15425	region	_
108-11	15426-15430	have	_
108-12	15431-15432	a	_
108-13	15433-15438	value	_
108-14	15439-15443	zero	_
108-15	15444-15445	,	_
108-16	15446-15449	but	_
108-17	15450-15453	the	_
108-18	15454-15460	values	_
108-19	15461-15467	inside	_
108-20	15468-15471	the	_
108-21	15472-15478	region	_
108-22	15479-15482	are	_
108-23	15483-15490	between	_
108-24	15491-15494	the	_
108-25	15495-15501	values	_
108-26	15502-15503	0	_
108-27	15504-15507	and	_
108-28	15508-15509	1	_
108-29	15510-15511	.	_

109-1	15512-15515	The	_
109-2	15516-15530	Harvard-Oxford	_
109-3	15531-15536	atlas	_
109-4	15537-15539	is	_
109-5	15540-15541	a	_
109-6	15542-15553	probability	_
109-7	15554-15557	map	_
109-8	15558-15560	so	_
109-9	15561-15564	the	_
109-10	15565-15570	voxel	_
109-11	15571-15577	values	_
109-12	15578-15584	inside	_
109-13	15585-15586	a	_
109-14	15587-15593	region	_
109-15	15594-15602	increase	_
109-16	15603-15605	as	_
109-17	15606-15609	the	_
109-18	15610-15620	likelihood	_
109-19	15621-15623	of	_
109-20	15624-15629	being	_
109-21	15630-15632	in	_
109-22	15633-15636	the	_
109-23	15637-15643	region	_
109-24	15644-15653	increases	_
109-25	15654-15655	.	_

110-1	15656-15665	Therefore	_
110-2	15666-15667	,	_
110-3	15668-15671	the	_
110-4	15672-15686	regionCoverage	_
110-5	15687-15690	for	_
110-6	15691-15694	the	_
110-7	15695-15709	Harvard-Oxford	_
110-8	15710-15715	atlas	_
110-9	15716-15718	is	_
110-10	15719-15726	percent	_
110-11	15727-15737	likelihood	_
110-12	15738-15740	of	_
110-13	15741-15746	being	_
110-14	15747-15748	a	_
110-15	15749-15757	specific	_
110-16	15758-15764	region	_
110-17	15765-15767	as	_
110-18	15768-15775	opposed	_
110-19	15776-15778	to	_
110-20	15779-15784	being	_
110-21	15785-15786	a	_
110-22	15787-15791	flat	_
110-23	15792-15800	coverage	_
110-24	15801-15803	or	_
110-25	15804-15811	overlap	_
110-26	15812-15814	of	_
110-27	15815-15818	the	_
110-28	15819-15825	region	_
110-29	15826-15827	.	_

111-1	15828-15835	Feature	_
111-2	15836-15845	selection	_
111-3	15846-15849	and	_
111-4	15850-15864	classification	_
111-5	15865-15879	Classification	_
111-6	15880-15883	was	_
111-7	15884-15893	performed	_
111-8	15894-15899	using	_
111-9	15900-15904	Weka	_
111-10	15905-15906	,	_
111-11	15907-15908	a	_
111-12	15909-15915	widely	_
111-13	15916-15920	used	_
111-14	15921-15925	data	_
111-15	15926-15932	mining	_
111-16	15933-15936	and	_
111-17	15937-15951	classification	_
111-18	15952-15960	software	_
111-19	15961-15968	written	_
111-20	15969-15973	with	_
111-21	15974-15975	a	_
111-22	15976-15980	Java	_
111-23	15981-15989	platform	_
111-24	15990-15991	.	_

112-1	15992-15995	The	_
112-2	15996-15998	FC	_
112-3	15999-16002	and	_
112-4	16003-16006	DFC	_
112-5	16007-16015	matrices	_
112-6	16016-16020	were	_
112-7	16021-16030	converted	_
112-8	16031-16035	from	_
112-9	16036-16042	MATLAB	_
112-10	16043-16047	into	_
112-11	16048-16052	Weka	_
112-12	16053-16054	’	_
112-13	16055-16061	s.arff	_
112-14	16062-16066	data	_
112-15	16067-16073	format	_
112-16	16074-16076	to	_
112-17	16077-16079	be	_
112-18	16080-16090	compatible	_
112-19	16091-16095	with	_
112-20	16096-16099	the	_
112-21	16100-16104	Weka	_
112-22	16105-16113	software	_
112-23	16114-16115	.	_

113-1	16116-16119	All	_
113-2	16120-16128	features	_
113-3	16129-16130	,	_
113-4	16131-16136	which	_
113-5	16137-16140	are	_
113-6	16141-16158	cross-correlation	_
113-7	16159-16171	coefficients	_
113-8	16172-16173	,	_
113-9	16174-16177	are	_
113-10	16178-16188	normalized	_
113-11	16189-16196	between	_
113-12	16197-16198	[	_
113-13	16199-16201	−1	_
113-14	16202-16203	,	_
113-15	16204-16205	1	_
113-16	16206-16207	]	_
113-17	16208-16209	;	_
113-18	16210-16217	however	_
113-19	16218-16219	,	_
113-20	16220-16222	no	_
113-21	16223-16238	standardization	_
113-22	16239-16240	(	_
113-23	16241-16250	zero-mean	_
113-24	16251-16252	,	_
113-25	16253-16266	unit-standard	_
113-26	16267-16276	deviation	_
113-27	16277-16278	)	_
113-28	16279-16282	was	_
113-29	16283-16290	applied	_
113-30	16291-16293	to	_
113-31	16294-16297	the	_
113-32	16298-16305	dataset	_
113-33	16306-16307	.	_

114-1	16308-16312	Each	_
114-2	16313-16319	column	_
114-3	16320-16321	(	_
114-4	16322-16324	28	_
114-5	16325-16332	columns	_
114-6	16333-16335	in	_
114-7	16336-16338	FC	_
114-8	16339-16340	,	_
114-9	16341-16346	1,232	_
114-10	16347-16354	columns	_
114-11	16355-16357	in	_
114-12	16358-16361	DFC	_
114-13	16362-16363	)	_
114-14	16364-16366	in	_
114-15	16367-16370	the	_
114-16	16371-16374	two	_
114-17	16375-16383	matrices	_
114-18	16384-16387	was	_
114-19	16388-16397	initially	_
114-20	16398-16408	considered	_
114-21	16409-16410	a	_
114-22	16411-16418	feature	_
114-23	16419-16421	to	_
114-24	16422-16424	be	_
114-25	16425-16429	used	_
114-26	16430-16432	in	_
114-27	16433-16436	the	_
114-28	16437-16451	classification	_
114-29	16452-16453	.	_

115-1	16454-16457	The	_
115-2	16458-16461	SVM	_
115-3	16462-16476	classification	_
115-4	16477-16486	algorithm	_
115-5	16487-16491	from	_
115-6	16492-16498	LIBSVM	_
115-7	16499-16500	,	_
115-8	16501-16502	a	_
115-9	16503-16510	popular	_
115-10	16511-16515	open	_
115-11	16516-16522	source	_
115-12	16523-16530	machine	_
115-13	16531-16539	learning	_
115-14	16540-16547	library	_
115-15	16548-16549	,	_
115-16	16550-16553	was	_
115-17	16554-16558	used	_
115-18	16559-16560	.	_

116-1	16561-16567	During	_
116-2	16568-16582	classification	_
116-3	16583-16584	,	_
116-4	16585-16588	the	_
116-5	16589-16594	least	_
116-6	16595-16606	significant	_
116-7	16607-16609	IC	_
116-8	16610-16615	pairs	_
116-9	16616-16620	were	_
116-10	16621-16632	iteratively	_
116-11	16633-16640	reduced	_
116-12	16641-16644	one	_
116-13	16645-16647	at	_
116-14	16648-16649	a	_
116-15	16650-16654	time	_
116-16	16655-16656	,	_
116-17	16657-16659	in	_
116-18	16660-16665	order	_
116-19	16666-16668	to	_
116-20	16669-16678	determine	_
116-21	16679-16682	how	_
116-22	16683-16686	the	_
116-23	16687-16701	classification	_
116-24	16702-16710	accuracy	_
116-25	16711-16718	changed	_
116-26	16719-16724	after	_
116-27	16725-16732	removal	_
116-28	16733-16735	of	_
116-29	16736-16739	the	_
116-30	16740-16744	pair	_
116-31	16745-16746	.	_

117-1	16747-16753	Having	_
117-2	16754-16755	a	_
117-3	16756-16760	high	_
117-4	16761-16767	number	_
117-5	16768-16770	of	_
117-6	16771-16779	features	_
117-7	16780-16784	does	_
117-8	16785-16788	not	_
117-9	16789-16795	simply	_
117-10	16796-16801	yield	_
117-11	16802-16805	the	_
117-12	16806-16813	highest	_
117-13	16814-16828	classification	_
117-14	16829-16837	accuracy	_
117-15	16838-16841	for	_
117-16	16842-16851	nonlinear	_
117-17	16852-16866	classification	_
117-18	16867-16877	algorithms	_
117-19	16878-16882	such	_
117-20	16883-16885	as	_
117-21	16886-16889	SVM	_
117-22	16890-16891	,	_
117-23	16892-16895	and	_
117-24	16896-16898	in	_
117-25	16899-16906	general	_
117-26	16907-16911	when	_
117-27	16912-16915	the	_
117-28	16916-16922	number	_
117-29	16923-16925	of	_
117-30	16926-16933	samples	_
117-31	16934-16937	are	_
117-32	16938-16941	not	_
117-33	16942-16946	high	_
117-34	16947-16948	(	_
117-35	16949-16954	curse	_
117-36	16955-16957	of	_
117-37	16958-16972	dimensionality	_
117-38	16973-16974	)	_
117-39	16975-16976	.	_

118-1	16977-16986	Therefore	_
118-2	16987-16988	,	_
118-3	16989-16992	the	_
118-4	16993-16999	number	_
118-5	17000-17002	of	_
118-6	17003-17011	features	_
118-7	17012-17016	were	_
118-8	17017-17024	reduced	_
118-9	17025-17026	.	_

119-1	17027-17031	This	_
119-2	17032-17039	process	_
119-3	17040-17051	constitutes	_
119-4	17052-17055	the	_
119-5	17056-17061	first	_
119-6	17062-17066	step	_
119-7	17067-17069	in	_
119-8	17070-17077	feature	_
119-9	17078-17087	reduction	_
119-10	17088-17090	in	_
119-11	17091-17096	which	_
119-12	17097-17100	the	_
119-13	17101-17108	minimal	_
119-14	17109-17112	set	_
119-15	17113-17115	of	_
119-16	17116-17119	ICs	_
119-17	17120-17128	yielding	_
119-18	17129-17132	the	_
119-19	17133-17137	best	_
119-20	17138-17152	classification	_
119-21	17153-17161	accuracy	_
119-22	17162-17165	was	_
119-23	17166-17171	found	_
119-24	17172-17173	.	_

120-1	17174-17177	The	_
120-2	17178-17185	process	_
120-3	17186-17188	of	_
120-4	17189-17198	iterative	_
120-5	17199-17206	removal	_
120-6	17207-17209	of	_
120-7	17210-17212	IC	_
120-8	17213-17218	pairs	_
120-9	17219-17226	started	_
120-10	17227-17231	with	_
120-11	17232-17235	the	_
120-12	17236-17239	set	_
120-13	17240-17242	of	_
120-14	17243-17246	all	_
120-15	17247-17249	28	_
120-16	17250-17255	pairs	_
120-17	17256-17257	,	_
120-18	17258-17267	including	_
120-19	17268-17271	all	_
120-20	17272-17279	initial	_
120-21	17280-17287	feature	_
120-22	17288-17292	sets	_
120-23	17293-17297	used	_
120-24	17298-17300	in	_
120-25	17301-17304	SVM	_
120-26	17305-17319	classification	_
120-27	17320-17321	.	_

121-1	17322-17324	In	_
121-2	17325-17328	the	_
121-3	17329-17333	case	_
121-4	17334-17336	of	_
121-5	17337-17346	DFC-based	_
121-6	17347-17361	classification	_
121-7	17362-17363	,	_
121-8	17364-17367	the	_
121-9	17368-17376	features	_
121-10	17377-17387	associated	_
121-11	17388-17392	with	_
121-12	17393-17395	an	_
121-13	17396-17398	IC	_
121-14	17399-17403	pair	_
121-15	17404-17408	were	_
121-16	17409-17416	removed	_
121-17	17417-17420	all	_
121-18	17421-17429	together	_
121-19	17430-17432	as	_
121-20	17433-17434	a	_
121-21	17435-17440	group	_
121-22	17441-17442	,	_
121-23	17443-17447	i.e.	_
121-24	17448-17449	,	_
121-25	17450-17457	removal	_
121-26	17458-17460	of	_
121-27	17461-17463	an	_
121-28	17464-17466	IC	_
121-29	17467-17471	pair	_
121-30	17472-17480	required	_
121-31	17481-17488	removal	_
121-32	17489-17491	of	_
121-33	17492-17495	all	_
121-34	17496-17498	45	_
121-35	17499-17502	DFC	_
121-36	17503-17511	measures	_
121-37	17512-17520	computed	_
121-38	17521-17524	for	_
121-39	17525-17528	the	_
121-40	17529-17531	IC	_
121-41	17532-17536	pair	_
121-42	17537-17538	.	_

122-1	17539-17543	This	_
122-2	17544-17549	group	_
122-3	17550-17557	removal	_
122-4	17558-17565	process	_
122-5	17566-17569	was	_
122-6	17570-17574	only	_
122-7	17575-17583	specific	_
122-8	17584-17586	to	_
122-9	17587-17590	DFC	_
122-10	17591-17596	since	_
122-11	17597-17601	each	_
122-12	17602-17606	pair	_
122-13	17607-17609	in	_
122-14	17610-17612	FC	_
122-15	17613-17621	involves	_
122-16	17622-17626	only	_
122-17	17627-17630	one	_
122-18	17631-17633	FC	_
122-19	17634-17641	measure	_
122-20	17642-17643	,	_
122-21	17644-17647	not	_
122-22	17648-17649	a	_
122-23	17650-17655	group	_
122-24	17656-17658	of	_
122-25	17659-17661	45	_
122-26	17662-17670	features	_
122-27	17671-17673	as	_
122-28	17674-17676	in	_
122-29	17677-17680	DFC	_
122-30	17681-17682	.	_

123-1	17683-17685	In	_
123-2	17686-17689	the	_
123-3	17690-17699	beginning	_
123-4	17700-17702	of	_
123-5	17703-17706	DFC	_
123-6	17707-17718	experiments	_
123-7	17719-17720	,	_
123-8	17721-17724	the	_
123-9	17725-17731	number	_
123-10	17732-17734	of	_
123-11	17735-17743	features	_
123-12	17744-17747	was	_
123-13	17748-17750	28	_
123-14	17751-17752	×	_
123-15	17753-17755	45	_
123-16	17756-17757	,	_
123-17	17758-17765	whereas	_
123-18	17766-17768	FC	_
123-19	17769-17780	experiments	_
123-20	17781-17788	started	_
123-21	17789-17793	with	_
123-22	17794-17798	only	_
123-23	17799-17801	28	_
123-24	17802-17810	features	_
123-25	17811-17812	(	_
123-26	17813-17816	one	_
123-27	17817-17820	for	_
123-28	17821-17825	each	_
123-29	17826-17828	IC	_
123-30	17829-17833	pair	_
123-31	17834-17835	)	_
123-32	17836-17837	.	_

124-1	17838-17840	In	_
124-2	17841-17845	both	_
124-3	17846-17857	experiments	_
124-4	17858-17859	(	_
124-5	17860-17863	DFC	_
124-6	17864-17865	,	_
124-7	17866-17868	FC	_
124-8	17869-17870	)	_
124-9	17871-17872	,	_
124-10	17873-17876	the	_
124-11	17877-17881	pair	_
124-12	17882-17884	to	_
124-13	17885-17887	be	_
124-14	17888-17895	removed	_
124-15	17896-17898	in	_
124-16	17899-17903	each	_
124-17	17904-17913	iteration	_
124-18	17914-17918	were	_
124-19	17919-17927	selected	_
124-20	17928-17937	utilizing	_
124-21	17938-17939	a	_
124-22	17940-17946	weight	_
124-23	17947-17953	vector	_
124-24	17954-17955	(	_
124-25	17956-17961	where	_
124-26	17962-17963	n	_
124-27	17964-17965	=	_
124-28	17966-17968	28	_
124-29	17969-17972	for	_
124-30	17973-17975	FC	_
124-31	17976-17979	and	_
124-32	17980-17981	n	_
124-33	17982-17983	=	_
124-34	17984-17986	28	_
124-35	17987-17988	×	_
124-36	17989-17991	45	_
124-37	17992-17995	for	_
124-38	17996-17999	DFC	_
124-39	18000-18001	)	_
124-40	18002-18004	in	_
124-41	18005-18008	SVM	_
124-42	18009-18010	.	_

125-1	18011-18016	Since	_
125-2	18017-18021	each	_
125-3	18022-18027	entry	_
125-4	18028-18030	of	_
125-5	18031-18032	w	_
125-6	18033-18044	corresponds	_
125-7	18045-18047	to	_
125-8	18048-18049	a	_
125-9	18050-18057	feature	_
125-10	18058-18060	in	_
125-11	18061-18064	the	_
125-12	18065-18079	classification	_
125-13	18080-18087	problem	_
125-14	18088-18089	,	_
125-15	18090-18096	showed	_
125-16	18097-18101	that	_
125-17	18102-18105	the	_
125-18	18106-18112	larger	_
125-19	18113-18117	∣wj∣	_
125-20	18118-18119	,	_
125-21	18120-18121	j	_
125-22	18122-18123	≤	_
125-23	18124-18125	n	_
125-24	18126-18127	,	_
125-25	18128-18131	the	_
125-26	18132-18136	more	_
125-27	18137-18140	the	_
125-28	18141-18153	contribution	_
125-29	18154-18156	to	_
125-30	18157-18160	the	_
125-31	18161-18175	classification	_
125-32	18176-18184	decision	_
125-33	18185-18186	.	_

126-1	18187-18189	In	_
126-2	18190-18194	this	_
126-3	18195-18203	notation	_
126-4	18204-18205	,	_
126-5	18206-18207	n	_
126-6	18208-18210	is	_
126-7	18211-18214	the	_
126-8	18215-18221	number	_
126-9	18222-18224	of	_
126-10	18225-18233	features	_
126-11	18234-18236	in	_
126-12	18237-18240	the	_
126-13	18241-18255	classification	_
126-14	18256-18263	problem	_
126-15	18264-18265	,	_
126-16	18266-18269	and	_
126-17	18270-18279	n-element	_
126-18	18280-18281	w	_
126-19	18282-18288	vector	_
126-20	18289-18291	is	_
126-21	18292-18295	the	_
126-22	18296-18302	weight	_
126-23	18303-18309	vector	_
126-24	18310-18311	,	_
126-25	18312-18317	which	_
126-26	18318-18319	,	_
126-27	18320-18325	after	_
126-28	18326-18336	iterations	_
126-29	18337-18339	of	_
126-30	18340-18343	the	_
126-31	18344-18358	classification	_
126-32	18359-18368	algorithm	_
126-33	18369-18370	,	_
126-34	18371-18378	becomes	_
126-35	18379-18382	the	_
126-36	18383-18391	solution	_
126-37	18392-18394	of	_
126-38	18395-18398	the	_
126-39	18399-18413	classification	_
126-40	18414-18421	problem	_
126-41	18422-18423	.	_

127-1	18424-18426	Wj	_
127-2	18427-18429	is	_
127-3	18430-18433	the	_
127-4	18434-18437	jth	_
127-5	18438-18445	element	_
127-6	18446-18448	of	_
127-7	18449-18451	w.	_
127-8	18452-18461	Following	_
127-9	18462-18463	,	_
127-10	18464-18470	linear	_
127-11	18471-18474	SVM	_
127-12	18475-18486	classifiers	_
127-13	18487-18491	were	_
127-14	18492-18495	run	_
127-15	18496-18507	iteratively	_
127-16	18508-18509	,	_
127-17	18510-18518	removing	_
127-18	18519-18522	the	_
127-19	18523-18528	least	_
127-20	18529-18540	significant	_
127-21	18541-18545	pair	_
127-22	18546-18550	from	_
127-23	18551-18554	the	_
127-24	18555-18562	current	_
127-25	18563-18566	set	_
127-26	18567-18569	at	_
127-27	18570-18575	every	_
127-28	18576-18585	iteration	_
127-29	18586-18587	.	_

128-1	18588-18591	The	_
128-2	18592-18600	stopping	_
128-3	18601-18610	condition	_
128-4	18611-18614	was	_
128-5	18615-18624	satisfied	_
128-6	18625-18629	once	_
128-7	18630-18633	all	_
128-8	18634-18637	but	_
128-9	18638-18641	one	_
128-10	18642-18646	pair	_
128-11	18647-18650	was	_
128-12	18651-18658	removed	_
128-13	18659-18660	.	_

129-1	18661-18663	In	_
129-2	18664-18668	each	_
129-3	18669-18678	iteration	_
129-4	18679-18680	,	_
129-5	18681-18693	participants	_
129-6	18694-18698	were	_
129-7	18699-18709	classified	_
129-8	18710-18715	using	_
129-9	18716-18719	the	_
129-10	18720-18733	leave-one-out	_
129-11	18734-18735	(	_
129-12	18736-18739	LOO	_
129-13	18740-18741	)	_
129-14	18742-18747	model	_
129-15	18748-18758	validation	_
129-16	18759-18765	method	_
129-17	18766-18767	.	_

130-1	18768-18771	The	_
130-2	18772-18775	LOO	_
130-3	18776-18782	scheme	_
130-4	18783-18785	is	_
130-5	18786-18789	the	_
130-6	18790-18800	exhaustive	_
130-7	18801-18808	version	_
130-8	18809-18811	of	_
130-9	18812-18818	k-fold	_
130-10	18819-18835	cross-validation	_
130-11	18836-18840	with	_
130-12	18841-18842	k	_
130-13	18843-18844	=	_
130-14	18845-18846	N	_
130-15	18847-18848	=	_
130-16	18849-18851	83	_
130-17	18852-18855	and	_
130-18	18856-18862	avoids	_
130-19	18863-18866	the	_
130-20	18867-18885	combination-driven	_
130-21	18886-18897	calculation	_
130-22	18898-18905	problem	_
130-23	18906-18908	of	_
130-24	18909-18915	k-fold	_
130-25	18916-18932	cross-validation	_
130-26	18933-18934	.	_

131-1	18935-18937	In	_
131-2	18938-18940	an	_
131-3	18941-18944	LOO	_
131-4	18945-18951	scheme	_
131-5	18952-18953	,	_
131-6	18954-18957	one	_
131-7	18958-18962	test	_
131-8	18963-18974	participant	_
131-9	18975-18976	,	_
131-10	18977-18978	S	_
131-11	18979-18980	,	_
131-12	18981-18983	is	_
131-13	18984-18992	excluded	_
131-14	18993-18997	from	_
131-15	18998-19001	the	_
131-16	19002-19009	overall	_
131-17	19010-19015	group	_
131-18	19016-19018	of	_
131-19	19019-19020	N	_
131-20	19021-19022	=	_
131-21	19023-19025	83	_
131-22	19026-19027	,	_
131-23	19028-19031	and	_
131-24	19032-19034	it	_
131-25	19035-19037	is	_
131-26	19038-19048	classified	_
131-27	19049-19051	to	_
131-28	19052-19054	be	_
131-29	19055-19062	control	_
131-30	19063-19065	or	_
131-31	19066-19068	CD	_
131-32	19069-19074	using	_
131-33	19075-19078	the	_
131-34	19079-19084	model	_
131-35	19085-19090	built	_
131-36	19091-19096	based	_
131-37	19097-19099	on	_
131-38	19100-19103	the	_
131-39	19104-19113	remaining	_
131-40	19114-19115	N	_
131-41	19116-19117	–	_
131-42	19118-19119	S	_
131-43	19120-19121	=	_
131-44	19122-19124	82	_
131-45	19125-19137	participants	_
131-46	19138-19139	,	_
131-47	19140-19145	which	_
131-48	19146-19148	is	_
131-49	19149-19152	the	_
131-50	19153-19161	training	_
131-51	19162-19167	group	_
131-52	19168-19169	.	_

132-1	19170-19171	S	_
132-2	19172-19174	is	_
132-3	19175-19179	also	_
132-4	19180-19186	called	_
132-5	19187-19190	the	_
132-6	19191-19201	validation	_
132-7	19202-19213	participant	_
132-8	19214-19215	.	_

133-1	19216-19220	This	_
133-2	19221-19235	classification	_
133-3	19236-19243	process	_
133-4	19244-19246	is	_
133-5	19247-19255	repeated	_
133-6	19256-19257	N	_
133-7	19258-19259	=	_
133-8	19260-19262	83	_
133-9	19263-19268	times	_
133-10	19269-19270	,	_
133-11	19271-19275	once	_
133-12	19276-19279	for	_
133-13	19280-19284	each	_
133-14	19285-19287	of	_
133-15	19288-19291	the	_
133-16	19292-19304	participants	_
133-17	19305-19306	.	_

134-1	19307-19310	The	_
134-2	19311-19319	accuracy	_
134-3	19320-19322	of	_
134-4	19323-19328	model	_
134-5	19329-19331	is	_
134-6	19332-19340	reported	_
134-7	19341-19343	in	_
134-8	19344-19348	each	_
134-9	19349-19353	case	_
134-10	19354-19355	.	_

135-1	19356-19360	Note	_
135-2	19361-19365	that	_
135-3	19366-19369	SVM	_
135-4	19370-19384	classification	_
135-5	19385-19391	models	_
135-6	19392-19400	obtained	_
135-7	19401-19404	for	_
135-8	19405-19409	each	_
135-9	19410-19418	training	_
135-10	19419-19426	dataset	_
135-11	19427-19433	result	_
135-12	19434-19436	in	_
135-13	19437-19446	different	_
135-14	19447-19450	but	_
135-15	19451-19458	similar	_
135-16	19459-19473	classification	_
135-17	19474-19480	models	_
135-18	19481-19482	(	_
135-19	19483-19484	a	_
135-20	19485-19494	hyperline	_
135-21	19495-19497	in	_
135-22	19498-19514	multidimensional	_
135-23	19515-19520	space	_
135-24	19521-19522	)	_
135-25	19523-19527	even	_
135-26	19528-19530	if	_
135-27	19531-19534	the	_
135-28	19535-19538	SVM	_
135-29	19539-19541	is	_
135-30	19542-19549	trained	_
135-31	19550-19554	with	_
135-32	19555-19562	exactly	_
135-33	19563-19566	the	_
135-34	19567-19571	same	_
135-35	19572-19582	parameters	_
135-36	19583-19586	and	_
135-37	19587-19598	constraints	_
135-38	19599-19600	.	_

136-1	19601-19603	In	_
136-2	19604-19611	general	_
136-3	19612-19613	,	_
136-4	19614-19615	a	_
136-5	19616-19623	dataset	_
136-6	19624-19628	with	_
136-7	19629-19640	significant	_
136-8	19641-19652	informative	_
136-9	19653-19661	features	_
136-10	19662-19667	would	_
136-11	19668-19670	be	_
136-12	19671-19675	more	_
136-13	19676-19682	robust	_
136-14	19683-19685	to	_
136-15	19686-19693	removal	_
136-16	19694-19696	of	_
136-17	19697-19698	a	_
136-18	19699-19709	particular	_
136-19	19710-19711	S	_
136-20	19712-19713	,	_
136-21	19714-19722	assuming	_
136-22	19723-19727	that	_
136-23	19728-19731	the	_
136-24	19732-19737	other	_
136-25	19738-19750	participants	_
136-26	19751-19754	who	_
136-27	19755-19758	are	_
136-28	19759-19761	of	_
136-29	19762-19765	the	_
136-30	19766-19770	same	_
136-31	19771-19776	class	_
136-32	19777-19779	as	_
136-33	19780-19781	S	_
136-34	19782-19786	will	_
136-35	19787-19792	cover	_
136-36	19793-19796	the	_
136-37	19797-19804	missing	_
136-38	19805-19816	information	_
136-39	19817-19825	excluded	_
136-40	19826-19828	by	_
136-41	19829-19832	the	_
136-42	19833-19840	removal	_
136-43	19841-19843	of	_
136-44	19844-19846	S.	_
136-45	19847-19854	Because	_
136-46	19855-19857	of	_
136-47	19858-19861	the	_
136-48	19862-19868	nature	_
136-49	19869-19871	of	_
136-50	19872-19875	SVM	_
136-51	19876-19877	’	_
136-52	19878-19879	s	_
136-53	19880-19885	heavy	_
136-54	19886-19896	dependence	_
136-55	19897-19899	to	_
136-56	19900-19909	parameter	_
136-57	19910-19919	selection	_
136-58	19920-19921	,	_
136-59	19922-19924	in	_
136-60	19925-19929	each	_
136-61	19930-19939	iteration	_
136-62	19940-19941	,	_
136-63	19942-19950	training	_
136-64	19951-19954	and	_
136-65	19955-19969	classification	_
136-66	19970-19974	were	_
136-67	19975-19979	done	_
136-68	19980-19985	using	_
136-69	19986-19993	various	_
136-70	19994-20004	parameters	_
136-71	20005-20008	and	_
136-72	20009-20016	kernels	_
136-73	20017-20018	.	_

137-1	20019-20022	The	_
137-2	20023-20027	list	_
137-3	20028-20030	of	_
137-4	20031-20041	parameters	_
137-5	20042-20045	and	_
137-6	20046-20053	kernels	_
137-7	20054-20056	is	_
137-8	20057-20065	provided	_
137-9	20066-20068	in	_
137-10	20069-20074	Table	_
137-11	20075-20076	3	_
137-12	20077-20078	.	_

138-1	20079-20082	The	_
138-2	20083-20093	parameters	_
138-3	20094-20098	used	_
138-4	20099-20102	for	_
138-5	20103-20112	DFC-based	_
138-6	20113-20120	results	_
138-7	20121-20122	,	_
138-8	20123-20128	which	_
138-9	20129-20136	provide	_
138-10	20137-20140	the	_
138-11	20141-20145	best	_
138-12	20146-20160	classification	_
138-13	20161-20165	with	_
138-14	20166-20167	7	_
138-15	20168-20170	IC	_
138-16	20171-20176	pairs	_
138-17	20177-20178	,	_
138-18	20179-20182	are	_
138-19	20183-20191	provided	_
138-20	20192-20194	in	_
138-21	20195-20199	bold	_
138-22	20200-20204	font	_
138-23	20205-20206	.	_

